JP2018108116A - Method for producing royal jelly material, royal jelly material, royal jelly-containing food and drink, and royal jelly-containing cosmetic - Google Patents
Method for producing royal jelly material, royal jelly material, royal jelly-containing food and drink, and royal jelly-containing cosmetic Download PDFInfo
- Publication number
- JP2018108116A JP2018108116A JP2018071633A JP2018071633A JP2018108116A JP 2018108116 A JP2018108116 A JP 2018108116A JP 2018071633 A JP2018071633 A JP 2018071633A JP 2018071633 A JP2018071633 A JP 2018071633A JP 2018108116 A JP2018108116 A JP 2018108116A
- Authority
- JP
- Japan
- Prior art keywords
- royal jelly
- yeast
- powder
- content
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940109850 royal jelly Drugs 0.000 title claims abstract description 183
- 239000000463 material Substances 0.000 title claims abstract description 77
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 235000013305 food Nutrition 0.000 title claims abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 151
- 239000007787 solid Substances 0.000 claims abstract description 63
- 229930091371 Fructose Natural products 0.000 claims abstract description 24
- 239000005715 Fructose Substances 0.000 claims abstract description 24
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 24
- 239000008103 glucose Substances 0.000 claims abstract description 24
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 23
- 230000002776 aggregation Effects 0.000 claims abstract description 14
- 238000004220 aggregation Methods 0.000 claims abstract description 9
- 238000000855 fermentation Methods 0.000 claims description 85
- 230000004151 fermentation Effects 0.000 claims description 85
- 238000001035 drying Methods 0.000 claims description 55
- 239000000047 product Substances 0.000 claims description 44
- 229920001353 Dextrin Polymers 0.000 claims description 33
- 239000004375 Dextrin Substances 0.000 claims description 33
- 235000019425 dextrin Nutrition 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 229920002472 Starch Polymers 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 235000019698 starch Nutrition 0.000 claims description 14
- 239000008107 starch Substances 0.000 claims description 12
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000013325 dietary fiber Nutrition 0.000 claims description 6
- 230000002401 inhibitory effect Effects 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 235000021245 dietary protein Nutrition 0.000 claims description 4
- 239000012265 solid product Substances 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 abstract description 54
- 238000002845 discoloration Methods 0.000 abstract description 21
- 239000000126 substance Substances 0.000 abstract description 12
- 238000013329 compounding Methods 0.000 abstract 1
- 238000010586 diagram Methods 0.000 abstract 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 142
- 239000000843 powder Substances 0.000 description 90
- 238000002360 preparation method Methods 0.000 description 90
- 238000011282 treatment Methods 0.000 description 73
- 239000000243 solution Substances 0.000 description 53
- 238000012360 testing method Methods 0.000 description 52
- 239000003826 tablet Substances 0.000 description 41
- 102000004190 Enzymes Human genes 0.000 description 29
- 108090000790 Enzymes Proteins 0.000 description 29
- 229940088598 enzyme Drugs 0.000 description 29
- KUPHXIFBKAORGY-UHFFFAOYSA-N 2-amino-3-iodo-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(N)=C1I KUPHXIFBKAORGY-UHFFFAOYSA-N 0.000 description 26
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 26
- 230000002829 reductive effect Effects 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000008859 change Effects 0.000 description 14
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 12
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- WXBXVVIUZANZAU-UHFFFAOYSA-N 2E-decenoic acid Natural products CCCCCCCC=CC(O)=O WXBXVVIUZANZAU-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- WXBXVVIUZANZAU-CMDGGOBGSA-N trans-2-decenoic acid Chemical compound CCCCCCC\C=C\C(O)=O WXBXVVIUZANZAU-CMDGGOBGSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 5
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 5
- 229920001661 Chitosan Polymers 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 5
- 229920000161 Locust bean gum Polymers 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229920000881 Modified starch Polymers 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 238000005054 agglomeration Methods 0.000 description 5
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 5
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 5
- 239000007857 degradation product Substances 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 239000001341 hydroxy propyl starch Substances 0.000 description 5
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 5
- 229940029339 inulin Drugs 0.000 description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 5
- 235000010420 locust bean gum Nutrition 0.000 description 5
- 239000000711 locust bean gum Substances 0.000 description 5
- 235000010413 sodium alginate Nutrition 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- 229940005550 sodium alginate Drugs 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 4
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 4
- 239000008108 microcrystalline cellulose Substances 0.000 description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 description 4
- 238000013207 serial dilution Methods 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 2
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 2
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 2
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- -1 aspergylopeptidase A Proteins 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229940045110 chitosan Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 108010054377 Mannosidases Proteins 0.000 description 1
- 102000001696 Mannosidases Human genes 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004186 food analysis Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000011899 heat drying method Methods 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Jellies, Jams, And Syrups (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
【課題】ローヤルゼリーの有用成分の目減りを最小限に抑えつつ、経時的な外観の変色を抑制することができるローヤルゼリー素材を提供する。【解決手段】ローヤルゼリーを酵母発酵処理した後、乾燥して、褐変の抑制された乾燥固形状物を得るローヤルゼリー素材の製造方法である。また、ローヤルゼリーを酵母発酵処理した後、乾燥して、凝集の抑制された乾燥固形状物を得るローヤルゼリー素材の製造方法である。また、ローヤルゼリーの酵母発酵物であって、ローヤルゼリー由来のグルコース及びフルクトースからなる糖質の合計含有量が乾燥固形分換算で10質量%以下とされている該ローヤルゼリーの酵母発酵物を含み、乾燥固形状であるローヤルゼリー素材である。このローヤルゼリー素材は、飲食品や化粧料への配合素材として好適に利用できる。【選択図】なしPROBLEM TO BE SOLVED: To provide a royal jelly material capable of suppressing discoloration of appearance over time while minimizing the loss of useful components of royal jelly. SOLUTION: This is a method for producing a royal jelly material, in which royal jelly is fermented with yeast and then dried to obtain a dry solid substance in which browning is suppressed. Further, it is a method for producing a royal jelly material, in which royal jelly is fermented with yeast and then dried to obtain a dry solid substance in which aggregation is suppressed. Further, the royal jelly yeast fermented product containing the royal jelly yeast fermented product having a total content of sugar consisting of glucose and fructose derived from royal jelly of 10% by mass or less in terms of dry solid content, and dried solid. It is a royal jelly material that has a shape. This royal jelly material can be suitably used as a compounding material for foods and drinks and cosmetics. [Selection diagram] None
Description
本発明は、ローヤルゼリーを酵母発酵処理してなるローヤルゼリー素材、そのローヤルゼリー素材を利用した飲食品、及びそのローヤルゼリー素材を利用した化粧料に関する。 The present invention relates to a royal jelly material obtained by subjecting royal jelly to yeast fermentation, a food and drink using the royal jelly material, and a cosmetic using the royal jelly material.
ローヤルゼリーは、羽化後3〜15日の雌のミツバチが下咽頭腺及び大腮腺から分泌する分泌物を混合して作るクリーム状の物質で、特有のタンパク質、脂肪酸、ミネラル等を含有し、血圧降下作用、抗腫瘍作用、創傷治癒促進、抗菌作用等の種々の機能性を有することが報告されている。したがって、従来、ローヤルゼリーは、栄養価の高い健康食品のみならず、医薬品、化粧品等の用途にも用いられてきた。 Royal jelly is a cream-like substance made by mixing secretions secreted from the hypopharyngeal gland and the greater vaginal gland by female honeybees 3 to 15 days after emergence, containing specific proteins, fatty acids, minerals, etc., and lowering blood pressure It has been reported to have various functions such as action, antitumor action, promotion of wound healing, and antibacterial action. Therefore, conventionally, royal jelly has been used not only for health foods with high nutritional value but also for uses such as pharmaceuticals and cosmetics.
しかしながら、ローヤルゼリーは、保存安定性が悪く、経時的に外観が変色するという問題があった。そこで、例えば、特許文献1には、ローヤルゼリーと、デンプン及びデキストロース当量が18以下のデキストリンから選ばれる少なくとも一種とを、溶媒に溶解した後、凍結乾燥することにより得られるローヤルゼリー含有組成物が開示され、そのように構成した組成物においては、経時的な外観の変色が抑制されることが記載されている。 However, the royal jelly has a problem that the storage stability is poor and the appearance changes with time. Thus, for example, Patent Document 1 discloses a royal jelly-containing composition obtained by dissolving royal jelly and at least one selected from starch and dextrin having a dextrose equivalent of 18 or less in a solvent and then freeze-drying. In the composition thus configured, it is described that discoloration of the appearance over time is suppressed.
一方、ローヤルゼリーの機能性をより優れたものとするために様々な処理が行われている。一例を挙げれば、例えば、特許文献2には、ローヤルゼリーを微生物で発酵させて得られる発酵物が開示され、かかる発酵物が、発酵前のローヤルゼリーよりも強い線維芽細胞賦活作用と細胞内チロシナーゼ活性抑制作用とを有しており、保存安定性にも優れ、化粧料への配合素材として好適であることが記載されている。 On the other hand, various treatments are performed in order to improve the functionality of the royal jelly. As an example, for example, Patent Document 2 discloses a fermented product obtained by fermenting royal jelly with a microorganism, and the fermented product has a stronger fibroblast activation action and intracellular tyrosinase activity than the royal jelly before fermentation. It has a suppressive action, is excellent in storage stability, and is described as being suitable as a blending material for cosmetics.
しかしながら、特許文献1に記載された方法によるデンプン等の添加だけでは変色抑制効果が十分ではなかった。また、変色抑制効果を得るための相当量でデンプン等を添加する必要があるので、得られる素材の全体中に含まれるローヤルゼリー成分の割合が目減りしてしまうという問題があった。一方、特許文献2には、ローヤルゼリーの乳酸菌発酵液について、それが沈殿・濁り、変色・着色などの保存安定性に優れていることが記載されているが、錠剤等の固形状の形態に調製されたときも同様の効果が認められるかどうか、明らかではなく、また、微生物として酵母を用いたときにも同様の効果が認められるか、明らかではなかった。 However, only the addition of starch or the like by the method described in Patent Document 1 has not been sufficient in discoloration suppressing effect. Moreover, since it is necessary to add starch etc. in a considerable quantity for obtaining the discoloration inhibitory effect, there existed a problem that the ratio of the royal jelly component contained in the whole of the obtained raw material will decrease. On the other hand, Patent Document 2 describes a royal jelly lactic acid bacteria fermentation solution that is excellent in storage stability such as precipitation / turbidity, discoloration / coloring, etc., but is prepared in a solid form such as a tablet. It was not clear whether or not the same effect was observed when it was applied, and it was not clear whether or not the same effect was observed when yeast was used as the microorganism.
よって、本発明の目的は、ローヤルゼリーの有用成分の目減りを最小限に抑えつつ、経時的な外観の変色を抑制することができるローヤルゼリー素材を提供することにある。 Accordingly, an object of the present invention is to provide a royal jelly material that can suppress discoloration of appearance over time while minimizing the loss of useful components of royal jelly.
上記目的を達成するため、本発明者らが鋭意研究した結果、ローヤルゼリーを酵母発酵処理することにより、ローヤルゼリー製品の品質の1つの指標物質として知られるデセン酸の含有量を目減りさせることなく、ローヤルゼリー含有の糖分を顕著に減量させることができ、かかるローヤルゼリー素材は、経時的な外観の変色も抑制されることを見出し、本発明を完成するに至った。 In order to achieve the above object, as a result of intensive studies by the present inventors, the royal jelly is subjected to yeast fermentation treatment, thereby reducing the content of decenoic acid, which is known as one indicator substance of the quality of the royal jelly product, without reducing the content of decenoic acid. It has been found that the sugar content can be significantly reduced, and such a royal jelly material has also been found to suppress discoloration of the appearance over time, leading to the completion of the present invention.
すなわち、本発明の第1は、ローヤルゼリーを酵母発酵処理した後、乾燥して、褐変の抑制された乾燥固形状物を得るローヤルゼリー素材の製造方法を提供するものである。 That is, the first of the present invention is to provide a method for producing a royal jelly material, which is obtained by subjecting royal jelly to a yeast fermentation treatment and then drying to obtain a dried solid product in which browning is suppressed.
また、本発明の第2は、ローヤルゼリーを酵母発酵処理した後、乾燥して、凝集の抑制された乾燥固形状物を得るローヤルゼリー素材の製造方法を提供するものである。 The second aspect of the present invention is to provide a method for producing a royal jelly material, which is obtained by subjecting royal jelly to yeast fermentation and then drying to obtain a dried solid product in which aggregation is suppressed.
一方、本発明の第3は、ローヤルゼリーの酵母発酵物であって、ローヤルゼリー由来のグルコース及びフルクトースからなる糖質の合計含有量が乾燥固形分換算で10質量%以下とされている該ローヤルゼリーの酵母発酵物を含み、乾燥固形状であることを特徴とするローヤルゼリー素材を提供するものである。 On the other hand, the third of the present invention is a fermented yeast product of royal jelly, wherein the total content of saccharides consisting of royal jelly-derived glucose and fructose is 10% by mass or less in terms of dry solid content, The present invention provides a royal jelly material containing a fermented product and having a dry solid form.
上記の乾燥固形状であるローヤルゼリー素材においては、更に、乾燥助剤を含むことが好ましい。 In the royal jelly material which is the above-mentioned dry solid, it is preferable to further contain a drying aid.
また、上記の乾燥固形状であるローヤルゼリー素材においては、前記乾燥助剤が、該乾燥助剤によって褐変が抑制される有効量で含まれることが好ましい。 Moreover, in the royal jelly material which is the above-mentioned dry solid, it is preferable that the drying aid is contained in an effective amount capable of suppressing browning by the drying aid.
また、上記の乾燥固形状であるローヤルゼリー素材においては、前記乾燥助剤が、デンプン 、デキストリン、食物繊維、及びタンパク質からなる群から選ばれた1種又は2種以上の食用素材であることが好ましい。 In the royal jelly material that is in the above-mentioned dry solid state, the drying aid is preferably one or more edible materials selected from the group consisting of starch, dextrin, dietary fiber, and protein. .
また、本発明の第4は、ローヤルゼリーの酵母発酵物に、乾燥助剤を、該乾燥助剤によって褐変が抑制される有効量で添加して、乾燥固形状にすることを特徴とするローヤルゼリー素材の褐変抑制方法を提供するものである。 The fourth aspect of the present invention is a royal jelly material characterized in that a dry auxiliary is added to a fermented yeast product of royal jelly in an effective amount that suppresses browning by the dry auxiliary to form a dry solid. The browning suppression method of this is provided.
上記褐変抑制方法においては、前記乾燥助剤が、デンプン、デキストリン、食物繊維、及びタンパク質からなる群から選ばれた1種又は2種以上の食用素材であることが好ましい。 In the browning suppression method, the drying aid is preferably one or more edible materials selected from the group consisting of starch, dextrin, dietary fiber, and protein.
更に、本発明の第5は、上記の乾燥固形状であるローヤルゼリー素材を含有するローヤルゼリー含有飲食品を提供するものである。 Furthermore, 5th of this invention provides the royal jelly containing food / beverage products containing the royal jelly raw material which is said dry solid form.
更に、本発明の第6は、上記の乾燥固形状であるローヤルゼリー素材を含有するローヤルゼリー含有化粧料を提供するものである。 Furthermore, a sixth aspect of the present invention provides a royal jelly-containing cosmetic containing the above-mentioned royal jelly material that is in a dry solid state.
本発明によれば、ローヤルゼリーを酵母発酵処理することにより、ローヤルゼリー製品の品質の1つの指標物質として知られるデセン酸の含有量を目減りさせることなく、ローヤルゼリー含有の糖分を顕著に減量させることができ、これにより経時的な外観の変色が抑制されたローヤルゼリー素材を提供することができる。更に、かかるローヤルゼリー素材は、これを乾燥固形状にしたときの凝集も抑制される。 According to the present invention, by subjecting royal jelly to yeast fermentation, the sugar content of royal jelly can be significantly reduced without reducing the content of decenoic acid, which is known as one indicator substance of the quality of royal jelly products. Thus, it is possible to provide a royal jelly material in which discoloration of the appearance over time is suppressed. Furthermore, the royal jelly material is also prevented from agglomerating when it is made into a dry solid.
本発明において用いられるローヤルゼリーとしては、特にその形態、産地等に制限はなく、生ローヤルゼリーや、生ローヤルゼリーを乾燥させて粉末化したローヤルゼリー粉末等のいずれの形態のものを使用してもよい。産地としては、例えば、中国、台湾、日本等のアジア諸国、ヨーロッパ諸国、北アメリカ諸国、ブラジル等の南アメリカ諸国のいずれでもよい。更には、原料ローヤルゼリーとして、例えば、酸・アルカリ処理や加熱処理、微粒子化処理、限外濾過、亜臨界処理、これらの処理の組合わせ等の前処理を行ったものを用いてもよい。 The royal jelly used in the present invention is not particularly limited in form, production area, and the like, and any form such as raw royal jelly or royal jelly powder obtained by drying raw royal jelly and pulverizing it may be used. The production area may be any of Asian countries such as China, Taiwan and Japan, European countries, North American countries, and South American countries such as Brazil. Furthermore, as the raw material royal jelly, for example, an acid / alkali treatment, a heat treatment, a fine particle treatment, an ultrafiltration, a subcritical treatment, or a combination of these treatments may be used.
本発明において用いられる酵母としては、特にその種属等に制限はないが、食品安全性の観点からは、飲食品の製造等のために従来用いられている食経験の豊富な酵母菌株や酵母含有製剤等であることが好ましい。例えば、酵母菌株としてサッカロマイセス セレビシエ(Saccharomyces cerevisiae)等が好ましく例示され、酵母含有製剤としては、パンやアルコール飲料製造用のイースト製剤等が好ましく採用され得る。 The yeast used in the present invention is not particularly limited in its genus and the like, but from the viewpoint of food safety, yeast strains and yeasts with abundant food experience conventionally used for the production of foods and drinks, etc. It is preferable that it is a formulation containing. For example, Saccharomyces cerevisiae and the like are preferably exemplified as yeast strains, and yeast and yeast preparations for producing alcoholic beverages can be preferably employed as yeast-containing preparations.
本発明においては、上記ローヤルゼリーに上記酵母を作用させて、発酵処理を行なう。その条件等に特に制限はなく、適宜適当な条件を設定して酵母発酵物を得ることができるが、典型的な例を挙げると、ローヤルゼリーを適当な溶媒、例えば水(又は緩衝液)で所定倍率に希釈し、ローヤルゼリーを乾燥固形分換算で好ましくは2〜30質量%、より好ましくは2.5〜30質量%、更により好ましくは5〜30質量%、最も好ましくは10〜25質量%含有する液状基質とし、これに酵母を添加して、好ましくはpH5.5〜11、より好ましくはpH5.5〜10、更により好ましくはpH7〜8の条件下に振とうあるいは静置することなどにより行うことができる。酵母発酵に必要な酵母の栄養素は、ほぼローヤルゼリーのみで十分であるが、必要に応じて、例えば、ビタミン、ミネラル、アミノ酸等の栄養素を補填してもよい。あるいは本発明の作用効果を害しない範囲であれば、必要最小限の糖質を補填してもよい。また、温度条件としては、25〜35℃であることが好ましい。また、酵母の添加量としてはその液状基質の容量に対して酵母の生菌が最終濃度で1×105〜5×109個/mLとなるように添加することが好ましく、最終濃度で1×106〜2×108個/mLとなるように添加することがより好ましい。また、酵母発酵の処理時間としては、典型的には0.5時間〜7日間であり、より典型的には3時間〜5日間であり、更により典型的には24時間〜3日間である。酵母発酵の処理条件が、それぞれ上記範囲外であると、ローヤルゼリー含有の糖分を減量する等の作用効果を奏しない場合があるので、好ましくない。なお、「乾燥固形分換算」とは、水分を除いた部分の量に換算することをいう。水分は、従来周知の食品分析法である加熱乾燥法やカール・フィッシャー法等に基づいて測定することが可能である。 In the present invention, the yeast is allowed to act on the royal jelly to perform a fermentation treatment. There are no particular restrictions on the conditions and the like, and it is possible to obtain a fermented yeast product by appropriately setting appropriate conditions. To give a typical example, royal jelly is predetermined with an appropriate solvent such as water (or buffer). It is diluted to a magnification, and royal jelly is preferably 2 to 30% by mass, more preferably 2.5 to 30% by mass, even more preferably 5 to 30% by mass, and most preferably 10 to 25% by mass in terms of dry solid content. By adding yeast to this, it is preferably shaken or allowed to stand under conditions of pH 5.5-11, more preferably pH 5.5-10, and even more preferably pH 7-8. It can be carried out. As for the nutrients of yeast necessary for yeast fermentation, only royal jelly is sufficient. However, for example, nutrients such as vitamins, minerals and amino acids may be supplemented as necessary. Or as long as it is a range which does not injure the effect of this invention, you may supplement a necessary minimum carbohydrate. Moreover, as temperature conditions, it is preferable that it is 25-35 degreeC. Further, the amount of yeast added is preferably such that the final concentration of viable yeast is 1 × 10 5 to 5 × 10 9 cells / mL with respect to the volume of the liquid substrate. It is more preferable to add so that it may become * 10 < 6 > -2 * 10 < 8 > piece / mL. The processing time for yeast fermentation is typically 0.5 hours to 7 days, more typically 3 hours to 5 days, and even more typically 24 hours to 3 days. . If the processing conditions for yeast fermentation are outside the above ranges, there may be cases where the effect of reducing the amount of sugar contained in the royal jelly may not be achieved. In addition, "dry solid content conversion" means converting into the quantity of the part except a water | moisture content. The moisture can be measured based on a conventionally known food analysis method such as a heat drying method or a Karl Fischer method.
本発明においては、(1)酵母発酵処理前のローヤルゼリー、(2)酵母発酵処理中のローヤルゼリー及び/又はその発酵物、(3)酵母発酵処理後の発酵物、のそれぞれに対応する1つ又は2つ以上の段階又は工程において、酵素処理を行なってもよい。具体的には、酵素処理は、例えば、ローヤルゼリー及び/又はその発酵物、プロテアーゼ、多糖類分解酵素等の酵素、及び水(又は緩衝液)を含む反応液を、所定条件下でインキュベートすることにより実施され得る。そして、その際の処理条件は、酵素の種類、反応温度、酵素の力価等により適宜設定され得る。 In the present invention, (1) Royal jelly before yeast fermentation treatment, (2) Royal jelly during yeast fermentation treatment and / or its fermented product, (3) Fermented product after yeast fermentation treatment, Enzymatic treatment may be performed in two or more stages or steps. Specifically, the enzyme treatment is performed, for example, by incubating a reaction solution containing royal jelly and / or its fermented product, an enzyme such as a protease, a polysaccharide-degrading enzyme, and water (or a buffer solution) under predetermined conditions. Can be implemented. And the process conditions in that case can be suitably set by the kind of enzyme, reaction temperature, the titer of an enzyme, etc.
酵素処理のための酵素としては、例えば、プロテアーゼとしては、パパイン、ブロメライン、マイクロバイアル・アスパルティック・プロテアーゼの一種アスペルギロペプチダーゼA、ペプシン、パンクレアチン、バチルス・サブティリス(Bacillus subtilis)由来の中性プロテアーゼ(例えばプロテアーゼN「アマノ」G(アマノエンザイム社製))等が挙げられる。また、多糖類分解酵素としては、例えば、セルラーゼ、アビセラーゼ、ヘミセルラーゼ、グルコシダーゼ、マンナナーゼ(例えばスミチームACH(新日本化学工業社製))、マンノシダーゼ、ガラクトシダーゼ、キシラナーゼ等が挙げられる。 Examples of enzymes for enzyme treatment include, for example, papain, bromelain, a kind of microvial aspartic protease, aspergylopeptidase A, pepsin, pancreatin, and neutrality derived from Bacillus subtilis. Proteases (for example, protease N “Amano” G (manufactured by Amano Enzyme)) and the like. Examples of polysaccharide-degrading enzymes include cellulase, avicelase, hemicellulase, glucosidase, mannanase (eg, Sumiteam ACH (manufactured by Shin Nippon Chemical Industry Co., Ltd.)), mannosidase, galactosidase, xylanase and the like.
上記のようにして得られたローヤルゼリーの酵母発酵物は、それをそのまま液体の状態で本発明にかかるローヤルゼリー素材と成してもよく、濃縮等により溶媒を除いて濃縮液と成してもよく、更に、乾燥・粉末化して粉体と成してもよい。更には、加熱殺菌処理を施してもよく、酵母を生菌の状態で残存させてもよい。ただし、本発明にかかるローヤルゼリー素材の形態はこれらの形態に限られるものではない。 The royal jelly yeast fermented product obtained as described above may be used as it is in the liquid state to form the royal jelly material according to the present invention, or may be formed into a concentrated solution by removing the solvent by concentration or the like. Further, it may be dried and powdered to form a powder. Furthermore, a heat sterilization treatment may be performed, and the yeast may be left in a viable state. However, the form of the royal jelly material according to the present invention is not limited to these forms.
上記に説明したローヤルゼリーの酵母発酵処理により、後述の実施例でも示されるように、ローヤルゼリー含有の糖分が顕著に減量される一方で、ローヤルゼリー製品の品質の1つの指標物質として知られるデセン酸の含有量の目減りがない(あるいは、糖分の減量により相対的に増量される。)。また、上記に説明したローヤルゼリーの酵母発酵処理により、後述の実施例でも示されるように、経時的な外観の変色が抑制される(特に褐変が抑制される。)。このような変色抑制効果は、糖分の減量によりメーラード反応や酸化反応等の変色に関わる反応が抑制されたことが1つの原因として考えられる。また、上記に説明したローヤルゼリーの酵母発酵処理により、後述の実施例でも示されるように、乾燥固形状にしたときの凝集が抑制される。このような凝集抑制効果は、糖分の減量により乾燥固形状物を構成する粒子どうしの結着に関わる性質が変化したことが1つの原因として考えられる。 As described in the examples below, the royal jelly-containing yeast fermentation treatment described above significantly reduces the amount of sugar contained in the royal jelly, while containing decenoic acid, which is known as one indicator substance for the quality of royal jelly products. There is no reduction in the amount (or it is relatively increased by reducing the sugar content). In addition, the royal jelly yeast fermentation treatment described above suppresses discoloration of the appearance over time (particularly browning is suppressed), as shown in Examples described later. Such a discoloration suppressing effect is considered to be caused by a reaction related to discoloration such as a Maillard reaction or an oxidation reaction being suppressed by reducing the sugar content. In addition, the royal jelly yeast fermentation treatment described above suppresses agglomeration when dried into a solid form, as will be shown in the examples described later. One of the causes of such agglomeration suppressing effect is considered to be a change in the properties related to the binding of the particles constituting the dry solid material due to the reduction of the sugar content.
より具体的には、上記ローヤルゼリー素材は、グルコース及びフルクトースからなる糖質の合計含有量が乾燥固形分換算で10質量%以下とされていることが好ましく、8質量%以下とされていることがより好ましく、5質量%以下とされていることが更により好ましい。また、10−ヒドロキシ−2−デセン酸の含有量が乾燥固形分換算で5質量%以上とされていることが好ましく、6質量%以上とされていることがより好ましく、6〜15質量%とされていることが更により好ましく、6〜10質量%とされていることが最も好ましい。また、蛋白質及び/又はペプチドの合計含有量は、乾燥固形分換算で35質量%以上とされていることが好ましく、40質量%以上とされていることがより好ましく、40〜60質量%とされていることが更により好ましく、45〜55質量%とされていることが最も好ましい。 More specifically, in the royal jelly material, the total content of carbohydrates composed of glucose and fructose is preferably 10% by mass or less in terms of dry solid content, and may be 8% by mass or less. More preferably, it is still more preferably 5% by mass or less. Further, the content of 10-hydroxy-2-decenoic acid is preferably 5% by mass or more in terms of dry solid content, more preferably 6% by mass or more, and 6 to 15% by mass. It is still more preferable that it is 6-10 mass%. The total content of protein and / or peptide is preferably 35% by mass or more, more preferably 40% by mass or more, and 40 to 60% by mass in terms of dry solid content. It is still more preferable that it is 45-55 mass%.
なお、これらの物質の定量は、糖分やデセン酸については、周知の低分子分析方法、例えば、HPLC分析や超高速液体クロマトグラフ分析等によって行うことができる。また、蛋白質及び/又はペプチドについては、周知の蛋白質・ペプチド分析方法、例えば、BCA法、Bradford法、Lowry法等によって行うことができる。ただし、定量方法はこれらに限られるものではなく、当業者に周知の測定方法により、標準品の段階希釈液で予め作成された検量線にあてはめを行う等によって、適宜定量することが可能である。 Note that these substances can be quantified with respect to sugar and decenoic acid by well-known low molecular analysis methods such as HPLC analysis and ultra-high performance liquid chromatographic analysis. Moreover, about protein and / or a peptide, it can carry out by a well-known protein and peptide analysis method, for example, BCA method, Bradford method, Lowry method, etc. However, the quantification method is not limited to these, and can be appropriately quantified by fitting a calibration curve prepared in advance with a standard serial dilution by a measurement method well known to those skilled in the art. .
更に、本発明の別の態様においては、ローヤルゼリー素材は、上記に説明したローヤルゼリーの酵母発酵処理物であって、ローヤルゼリー由来のグルコース及びフルクトースからなる糖質の合計含有量が乾燥固形分換算で10質量%以下、より好ましくは8質量%以下、更に好ましくは5質量%以下である、そのローヤルゼリーの酵母発酵物を含み、乾燥固形状とされていることが好ましい。乾燥固形状物となすための乾燥手段は、公知の手段を利用でき、特に制限はない。例えば、凍結乾燥、噴霧乾燥、ドラム乾燥、熱風乾燥、真空乾燥などが挙げられる。なかでも、熱変性が少ないという理由から凍結乾燥が好ましい。ここで、「乾燥固形状」もしくは「乾燥固形状物」とは、粉末状の形態に限られず、例えば、顆粒状、錠剤状等の形態を含む意味である。また、このような乾燥固形状の形態のローヤルゼリー素材においては、その全体中に上記ローヤルゼリー酵母発酵処理物を10〜100質量%含有するものであることが好ましく、より典型的には30〜75質量%含有するものである。また、その水分含量が10質量%以下であればよく、5質量%以下であることがより好ましい。このような乾燥固形状と成すことにより、保存性の良いローヤルゼリー素材を提供することができる。 Furthermore, in another aspect of the present invention, the royal jelly material is the yeast fermented processed product of royal jelly described above, and the total content of carbohydrates composed of royal jelly-derived glucose and fructose is 10 in terms of dry solid content. It is preferable that the royal jelly yeast fermented product is contained in a dry solid form in an amount of not more than mass%, more preferably not more than 8 mass%, still more preferably not more than 5 mass%. A known means can be used as a drying means for obtaining a dry solid, and there is no particular limitation. Examples include freeze drying, spray drying, drum drying, hot air drying, and vacuum drying. Of these, lyophilization is preferred because of its low thermal denaturation. Here, the “dry solid” or “dry solid” is not limited to a powder form, and includes, for example, a granular form, a tablet form, and the like. Moreover, in the royal jelly raw material in such a dry solid form, it is preferable that 10 to 100% by mass of the royal jelly yeast fermentation product is contained in the whole, and more typically 30 to 75% by mass. % Content. Moreover, the water content should just be 10 mass% or less, and it is more preferable that it is 5 mass% or less. By forming such a dry solid, a royal jelly material having good storage stability can be provided.
また、本発明の好ましい態様において、上記ローヤルゼリー素材が乾燥固形状である場合には、更に、乾燥助剤を含むことがより好ましい。これによれば、乾燥助剤の配合によって、粉末状等の乾燥固形状の形態の維持が容易になるとともに、所定の場合には、経時的な外観の変色が更により一層抑制される(特に褐変が更により一層抑制される。)。その際、乾燥助剤は、糖分を減量したローヤルゼリー酵母発酵物を液体状、湿潤状等の形態から乾燥固形状と成すための調製工程に添加することがより好ましい。このとき使用する乾燥助剤としては、当業者に賦形剤等として周知の物質等を用いればよく、特に制限はない。例えば、下記表1に示すような賦形剤等が種々知られているので、これらを使用可能である。 Moreover, in the preferable aspect of this invention, when the said royal jelly raw material is dry solid form, it is more preferable that a drying adjuvant is further included. According to this, the blending of the drying aid facilitates the maintenance of a dry solid form such as a powder, and in a predetermined case, the discoloration of the appearance over time is further suppressed (in particular, Browning is even more suppressed.) In that case, it is more preferable that the drying aid is added to a preparation step for converting the fermented royal jelly yeast having a reduced sugar content from a liquid form, a wet form or the like into a dry solid form. The drying aid used at this time may be any substance known to those skilled in the art as an excipient, and is not particularly limited. For example, various excipients as shown in Table 1 below are known, and these can be used.
上記の態様に使用する乾燥助剤としては、1種類のものを単独で使用してもよく、2種類以上のものを併用してもよい。使用する乾燥助剤の含有量としては、所望する形態等に応じて乾燥助剤の種類を適宜選択し、含有量もそれに応じて適宜設定すればよいが、例えば、典型的には、上記ローヤルゼリー素材中に、乾燥助剤を乾燥固形分換算(複数添加する場合はその合計として)で1〜50質量%程度含有させることが好ましく、10〜20質量%程度含有させることがより好ましい。 As a drying aid used in the above embodiment, one type of drying aid may be used alone, or two or more types may be used in combination. As the content of the drying aid to be used, the type of the drying aid may be appropriately selected according to the desired form, and the content may be appropriately set accordingly. For example, typically, the above-mentioned royal jelly In the material, it is preferable to contain about 1 to 50% by mass, and more preferably about 10 to 20% by mass, in terms of dry solid content (when added in total, the total amount).
より具体的には、上記の態様に使用する乾燥助剤としては、ヒドロキシプロピルデンプン、還元デンプン分解物、α化デンプン等のデンプン類や、粉あめ(DE20〜40程度)、マルトデキストリン(DE10〜20程度)、デキストリン(DE10以下)、クラスターデキストリン、α-シクロデキストリン、γ−シクロデキストリン等のデキストリン類や、ペクチン、アルギン酸ナトリウム、イヌリン、ローカストビーンガム、セルロース、キトサン等の食物繊維類や、ゼラチン等のタンパク質類等が挙げられる。なかでも、粉末状等の乾燥固形状の形態への調製の容易化とともに、褐変を抑制する観点からは、ヒドロキシプロピルデンプン、α化デンプン、還元デンプン分解物等のデンプン類や、デキストリン(DE3)、デキストリン(DE11)、γ-シクロデキストリン、α-シクロデキストリン、クラスターデキストリン等のデキストリン類や、アルギン酸ナトリウム、キトサン、イヌリン、ローカストビーンガム、微結晶セルロース等の食物繊維類や、ゼラチン等のタンパク質類等が挙げられる。 More specifically, examples of the drying aid used in the above embodiment include starches such as hydroxypropyl starch, reduced starch degradation product, pregelatinized starch, powdered candy (DE20 to about 40), maltodextrin (DE10-10). About 20), dextrin (DE10 or lower), cluster dextrin, α-cyclodextrin, γ-cyclodextrin, etc., dietary fibers such as pectin, sodium alginate, inulin, locust bean gum, cellulose, chitosan, gelatin And the like. Among them, from the viewpoint of facilitating preparation into a dry solid form such as powder and suppressing browning, starches such as hydroxypropyl starch, pregelatinized starch, reduced starch degradation product, and dextrin (DE3) , Dextrins such as dextrin (DE11), γ-cyclodextrin, α-cyclodextrin, cluster dextrin, dietary fibers such as sodium alginate, chitosan, inulin, locust bean gum, microcrystalline cellulose, and proteins such as gelatin Etc.
本発明にかかるローヤルゼリー素材は、ローヤルゼリー含有飲食品の製造のために好ましく用いられる。すなわち、種々の飲食品用の素材又は基材を用いた飲食品の調製や加工等の際に、あるいはその素材又は基材自体の調製や加工等の際に、その原料の一部として添加することなどによってローヤルゼリー含有飲食品を成すことができる。その形態に特に制限はなく、液状、粉末状、ゲル状、固形状等であり得る。また、剤形としては、錠剤、カプセル剤、顆粒剤、ドリンク剤のいずれであってもよい。その中でも、吸湿性が抑えられることから、糖衣錠、セラック錠などのコーティング錠やカプセル剤であることが好ましい。また、その他の成分としてゲル化剤含有食品、糖類、香料、甘味料、油脂、基材、賦形剤、乾燥助剤、食品添加剤、副素材、増量剤等を適宜配合してもよい。 The royal jelly material according to the present invention is preferably used for the production of a royal jelly-containing food or drink. That is, it is added as a part of the raw material when preparing or processing food or drink using various materials or base materials for food or drink, or when preparing or processing the raw material or base material itself. The royal jelly containing food / beverage products can be comprised by things. There is no restriction | limiting in particular in the form, It may be liquid, a powder form, a gel form, solid form etc. Moreover, as a dosage form, any of a tablet, a capsule, a granule, and a drink may be sufficient. Of these, coated tablets and capsules such as sugar-coated tablets and shellac tablets are preferable because hygroscopicity can be suppressed. Moreover, you may mix | blend suitably gelatinizer containing foodstuffs, saccharides, a fragrance | flavor, a sweetener, fats and oils, a base material, an excipient | filler, a drying aid, a food additive, a subsidiary material, an extender etc. as another component.
本発明にかかるローヤルゼリー素材は、ローヤルゼリー含有化粧料の製造のために好ましく用いられる。すなわち、種々の化粧品用の素材又は基材を用いた化粧料の調製や加工等の際に、あるいはその素材又は基材自体の調製や加工等の際に、その原料の一部として添加することなどによってローヤルゼリー含有化粧料を成すことができる。その形態・剤形に特に制限はなく、乳液状、クリーム状、粉末状等であり得る。また、化粧品素材又は基材としては、一般に化粧料に共通して配合されるものであって、例えば、油分、精製水及びアルコールを主要成分として、界面活性剤、保湿剤、酸化防止剤、増粘剤、抗脂漏剤、血行促進剤、美白剤、pH調整剤、色素顔料、防腐剤、香料等が適宜配合され得る。 The royal jelly material according to the present invention is preferably used for the production of a royal jelly-containing cosmetic. That is, it is added as a part of the raw material when preparing or processing cosmetics using various cosmetic materials or base materials, or when preparing or processing the raw materials or base materials themselves. Royal jelly-containing cosmetics can be formed by such means. There is no restriction | limiting in particular in the form and dosage form, It may be emulsion, cream form, powder form, etc. In addition, as a cosmetic material or base material, it is generally blended in common with cosmetics, for example, oil, purified water and alcohol as main components, surfactant, moisturizer, antioxidant, A sticking agent, an antiseborrheic agent, a blood circulation promoter, a whitening agent, a pH adjuster, a pigment, a preservative, a fragrance and the like can be appropriately blended.
本発明にかかるローヤルゼリー素材は、ローヤルゼリー由来の特有のタンパク質、脂肪酸、ミネラル等を豊富に含有しているので、生体への様々な有益な効果が期待できる。よって、上記の態様に代え、あるいは加えて、例えば、健康食品、サプリメント、栄養補助食品、機能性食品、化粧品、医薬品、医薬部外品、動物用健康食品、動物用サプリメント、動物用栄養補助食品、動物用機能性食品、動物用医薬品、動物用医薬部外品など各種の製品形態で、あるいはそれら製品と組み合わせて使用されることが可能である。また、各種の飲食品や動物・魚類用飼料と組み合わせて使用されることが可能である。 Since the royal jelly material according to the present invention contains abundant royal jelly-derived specific proteins, fatty acids, minerals and the like, various beneficial effects on the living body can be expected. Therefore, instead of or in addition to the above-described embodiment, for example, health foods, supplements, nutritional supplements, functional foods, cosmetics, pharmaceuticals, quasi drugs, animal health foods, animal supplements, animal nutrition supplements It can be used in various product forms such as functional foods for animals, veterinary drugs, quasi drugs for animals, or in combination with these products. Further, it can be used in combination with various foods and drinks and animal and fish feeds.
以下に実施例を挙げて本発明について更に具体的に説明する。なお、これらの実施例は本発明の範囲を限定するものではない。 Hereinafter, the present invention will be described in more detail with reference to examples. In addition, these Examples do not limit the scope of the present invention.
<調製例1−1>
固形分34質量%の生ローヤルゼリーに対して蒸留水を加えて、その乾燥固形分含量が11質量%となるように調整し、これを攪拌して成分をよく溶解・分散させ、3Nの水酸化ナトリウム水溶液を用いてpHを7.0に調整した。このローヤルゼリー溶液(RJ溶液:以下、「ローヤルゼリー」を「RJ」と称する場合がある。)の100gに対して、市販のパン酵母含有製剤A500mgを添加し、好気条件下に30℃で24時間インキュベートすることにより、酵母発酵処理を行なった。酵母発酵処理後、80℃で30分間加熱殺菌し、その後に凍結乾燥、粉末化して、調製例1−1の酵母発酵RJ末を得た。
<Preparation Example 1-1>
Distilled water is added to a raw royal jelly having a solid content of 34% by mass, and the dry solid content is adjusted to 11% by mass, and this is stirred to dissolve and disperse the components well. The pH was adjusted to 7.0 using an aqueous sodium solution. 500 g of a commercial baker's yeast-containing preparation A is added to 100 g of this royal jelly solution (RJ solution: hereinafter, “royal jelly” may be referred to as “RJ”), and the mixture is subjected to aerobic conditions at 30 ° C. for 24 hours. The yeast fermentation process was performed by incubating. After the yeast fermentation treatment, the mixture was sterilized by heating at 80 ° C. for 30 minutes, and then freeze-dried and powdered to obtain a yeast fermentation RJ powder of Preparation Example 1-1.
<調製例1−2>
RJ溶液の100gに対して、パン酵母含有製剤Aの500mgに加えて、糖化酵素製剤(「グルクザイムAF6」天野エンザイム株式会社製)の100mgを添加した以外は、調製例1−1と同様にして、調製例1−2の酵母発酵RJ末を得た。
<Preparation Example 1-2>
In the same manner as in Preparation Example 1-1, 100 mg of the saccharification enzyme preparation (“Gluczyme AF6” manufactured by Amano Enzyme Inc.) was added to 100 g of the RJ solution in addition to 500 mg of the baker's yeast-containing preparation A. The yeast fermentation RJ powder of Preparation Example 1-2 was obtained.
<調製例2−1>
酵母含有製剤として、市販のパン酵母含有製剤Bを使用した以外は、調製例1−1と同様にして、調製例2−1の酵母発酵RJ末を得た。
<Preparation Example 2-1>
A yeast fermentation RJ powder of Preparation Example 2-1 was obtained in the same manner as Preparation Example 1-1 except that the commercially available baker's yeast-containing preparation B was used as the yeast-containing preparation.
<調製例2−2>
酵母含有製剤として、市販のパン酵母含有製剤Bを使用した以外は、調製例1−2と同様にして、調製例2−2の酵母発酵RJ末を得た。
<Preparation Example 2-2>
The yeast fermentation RJ powder of Preparation Example 2-2 was obtained in the same manner as Preparation Example 1-2 except that the commercially available baker's yeast-containing preparation B was used as the yeast-containing preparation.
<調製例3−1>
酵母含有製剤として、市販のパン酵母含有製剤Cを使用した以外は、調製例1−1と同様にして、調製例3−1の酵母発酵RJ末を得た。
<Preparation Example 3-1>
A yeast fermentation RJ powder of Preparation Example 3-1 was obtained in the same manner as Preparation Example 1-1 except that the commercially available baker's yeast-containing preparation C was used as the yeast-containing preparation.
<調製例3−2>
酵母含有製剤として、市販のパン酵母含有製剤Cを使用した以外は、調製例1−2と同様にして、調製例3−2の酵母発酵RJ末を得た。
<Preparation Example 3-2>
A yeast fermentation RJ powder of Preparation Example 3-2 was obtained in the same manner as Preparation Example 1-2, except that the commercially available baker's yeast-containing preparation C was used as the yeast-containing preparation.
<調製例4−1>
酵母含有製剤として、市販のパン酵母含有製剤Dを使用した以外は、調製例1−1と同様にして、調製例4−1の酵母発酵RJ末を得た。
<Preparation Example 4-1>
A yeast fermentation RJ powder of Preparation Example 4-1 was obtained in the same manner as Preparation Example 1-1 except that the commercially available baker's yeast-containing preparation D was used as the yeast-containing preparation.
<調製例4−2>
酵母含有製剤として、市販のパン酵母含有製剤Dを使用した以外は、調製例1−2と同様にして、調製例4−2の酵母発酵RJ末を得た。
<Preparation Example 4-2>
A yeast fermentation RJ powder of Preparation Example 4-2 was obtained in the same manner as Preparation Example 1-2 except that the commercially available baker's yeast-containing preparation D was used as the yeast-containing preparation.
<調製例5−1>
酵母含有製剤として、市販のパン酵母含有製剤Eを使用した以外は、調製例1−1と同様にして、調製例5−1の酵母発酵RJ末を得た。
<Preparation Example 5-1>
A yeast fermentation RJ powder of Preparation Example 5-1 was obtained in the same manner as Preparation Example 1-1 except that the commercially available baker's yeast-containing preparation E was used as the yeast-containing preparation.
<調製例5−2>
酵母含有製剤として、市販のパン酵母含有製剤Eを使用した以外は、調製例1−2と同様にして、調製例5−2の酵母発酵RJ末を得た。
<Preparation Example 5-2>
A yeast fermentation RJ powder of Preparation Example 5-2 was obtained in the same manner as Preparation Example 1-2 except that the commercially available baker's yeast-containing preparation E was used as the yeast-containing preparation.
<調製例6−1>
酵母含有製剤として、市販のパン酵母含有製剤Fを使用した以外は、調製例1−1と同様にして、調製例6−1の酵母発酵RJ末を得た。
<Preparation Example 6-1>
A yeast fermentation RJ powder of Preparation Example 6-1 was obtained in the same manner as Preparation Example 1-1 except that the commercially available baker's yeast-containing preparation F was used as the yeast-containing preparation.
<調製例6−2>
酵母含有製剤として、市販のパン酵母含有製剤Fを使用した以外は、調製例1−2と同様にして、調製例6−2の酵母発酵RJ末を得た。
<Preparation Example 6-2>
A yeast fermentation RJ powder of Preparation Example 6-2 was obtained in the same manner as Preparation Example 1-2, except that the commercially available baker's yeast-containing preparation F was used as the yeast-containing preparation.
[試験例1]
調製例1−1〜調製例6−2で得られた酵母発酵RJ末のそれぞれについて、その糖分含量を以下に示す方法で測定した。なお、比較のために、酵母発酵処理の原料としたRJ溶液や、酵母を添加直後に殺菌を行い、酵母発酵処理を施さないで調製例1−1と同様にして調製したRJ末についても、同様に、それらの糖分含量を測定した。
[Test Example 1]
About each of yeast fermentation RJ powder obtained by the preparation example 1-1 to the preparation example 6-2, the sugar content was measured by the method shown below. For comparison, the RJ solution used as a raw material for the yeast fermentation treatment and the RJ powder prepared in the same manner as in Preparation Example 1-1 without sterilization immediately after the addition of yeast, Similarly, their sugar content was measured.
(糖分含量の測定方法)
標準品(グルコース、フルクトース、スクロースその他の糖)50mgを50mL容のメスフラスコに合一して秤量し、50%アセトニトリルで1.00mg/mLに定容した。公比5で段階希釈し、0.20mg/mL、0.04mg/mLの標準溶液を調製した。また、各被測定検体については、その60mgを20mL容のメスフラスコに秤量し、50%アセトニトリルで定容し、0.20μmフィルターで濾過をして分析試料とした。分析にはHPLC−RID(示差屈折系)を使用し、各被測定検体について得られた測定値曲線下面積値を、別途上記標準溶液により予め作成した検量線にあてはめ、定量した。なお、HPLC−RID(示差屈折系)の分析条件は、以下のとおりとした。
(Measurement method of sugar content)
50 mg of standard products (glucose, fructose, sucrose and other sugars) were combined in a 50 mL volumetric flask and weighed, and the volume was adjusted to 1.00 mg / mL with 50% acetonitrile. Serial dilutions with a common ratio of 5 were made to prepare standard solutions of 0.20 mg / mL and 0.04 mg / mL. For each sample to be measured, 60 mg thereof was weighed into a 20 mL volumetric flask, fixed with 50% acetonitrile, and filtered through a 0.20 μm filter to obtain an analysis sample. For the analysis, HPLC-RID (differential refraction system) was used, and the area under the measurement value curve obtained for each sample to be measured was applied to a calibration curve separately prepared in advance using the above standard solution and quantified. The analysis conditions of HPLC-RID (differential refraction system) were as follows.
・移動相:72%アセトニトリル
・カラム:Cosmosil Sugar−D Pached Column
・流速:1mL/m
・検出:RI(30℃、ポジティブ)
・注入量10μL
-Mobile phase: 72% acetonitrile-Column: Cosmosil Sugar-D Pached Column
・ Flow rate: 1 mL / m
・ Detection: RI (30 ° C, positive)
・ Injection volume 10μL
その結果を表2に示す。 The results are shown in Table 2.
その結果、表2に示すように、酵母発酵処理を施さないで調製した対照のRJ末では糖分がほとんど減量されなかったのに対して、酵母発酵処理によりローヤルゼリー含有の糖分が顕著に減量され、なかでもグルコースやフルクトースの減量化が顕著であった。 As a result, as shown in Table 2, the sugar content was hardly reduced in the control RJ powder prepared without the yeast fermentation treatment, whereas the sugar content containing royal jelly was significantly reduced by the yeast fermentation treatment, In particular, the reduction of glucose and fructose was remarkable.
[試験例2]
ローヤルゼリー素材においてローヤルゼリー含有の糖分を減量することによるメリットを検証するため、以下に示す錠剤を調製した。
[Test Example 2]
In order to verify the merit of reducing the amount of sugar contained in the royal jelly material, the following tablets were prepared.
(錠剤1)
ローヤルゼリーの凍結乾燥製品(アピ株式会社製)を使用し、その192.5mgに対して、賦形剤を57.5mg使用して、1錠あたり250mgの錠剤を常法に従い打錠成形した。
(Tablet 1)
A royal jelly freeze-dried product (manufactured by API) was used, and 57.5 mg of the excipient was used with respect to 192.5 mg thereof.
(錠剤2)
ローヤルゼリーの酵素処理製品(アピ株式会社製)(10質量%の乾燥助剤を含有)を使用し、その192.5mgに対して、賦形剤を57.5mg使用して、1錠あたり250mgの錠剤を常法に従い打錠成形した。
(Tablet 2)
Using a royal jelly enzyme-treated product (manufactured by Api Co., Ltd.) (containing 10% by weight of a drying aid), with respect to 192.5 mg, 57.5 mg of excipient was used and 250 mg per tablet The tablets were tableted according to a conventional method.
(錠剤3)
調製例5−1と同様にして調製した酵母発酵RJ末を使用し、その192.5mgに対して、賦形剤を57.5mg使用して、1錠あたり250mgの錠剤を常法に従い打錠成形した。
(Tablet 3)
Yeast fermented RJ powder prepared in the same manner as in Preparation Example 5-1 was used, and 57.5 mg of excipient was used for 192.5 mg of the powder, and tablets of 250 mg per tablet were tableted according to a conventional method. Molded.
(錠剤4)
調製例5−1と同様にして調製した酵母発酵RJ末を使用し、調製例5−1と同様にローヤルゼリーの酵母発酵処理を行ない、その発酵処理液の固形分100質量部に対して、乾燥助剤を37質量部添加し、80℃で15分間加熱殺菌した後、凍結乾燥、粉末化した。得られた粉末の192.5mgに対して、賦形剤を57.5mg使用して、1錠あたり250mgの錠剤を常法に従い打錠成形した。
(Tablet 4)
Yeast fermentation RJ powder prepared in the same manner as in Preparation Example 5-1 was used, and royal jelly was subjected to yeast fermentation treatment in the same manner as in Preparation Example 5-1, and was dried with respect to 100 parts by mass of the solid content of the fermentation treatment liquid. After adding 37 parts by mass of an auxiliary agent and sterilizing by heating at 80 ° C. for 15 minutes, it was freeze-dried and powdered. Using 57.5 mg of the excipient with respect to 192.5 mg of the obtained powder, 250 mg tablets per tablet were tableted according to a conventional method.
(錠剤5)
調製例5−1と同様にローヤルゼリーの酵母発酵処理を行ない、その後さらに酵素処理を施した。具体的には、酵母発酵処理後のRJ溶液のpHを3Nの水酸化ナトリウム水溶液を用いてpH8.75に再調整し、その1500mLに対して、蛋白質分解酵素製剤(「スミチームFP−G」新日本化学工業株式会社製)の1.65gを添加し、50℃で3時間、酵素処理を行なった。その酵素処理液の固形分100質量部に対して、乾燥助剤を30質量部添加し、80℃で15分間加熱殺菌した後、凍結乾燥、粉末化した。得られた粉末の192.5mgに対して、賦形剤を57.5mg使用して、1錠あたり250mgの錠剤を常法に従い打錠成形した。
(Tablet 5)
The royal jelly was subjected to yeast fermentation in the same manner as in Preparation Example 5-1, followed by further enzyme treatment. Specifically, the pH of the RJ solution after the yeast fermentation treatment was readjusted to pH 8.75 using a 3N aqueous sodium hydroxide solution, and the proteolytic enzyme preparation (“Sumiteam FP-G” 1.65 g (manufactured by Nippon Chemical Industry Co., Ltd.) was added, and enzyme treatment was performed at 50 ° C. for 3 hours. 30 parts by mass of a drying aid was added to 100 parts by mass of the solid content of the enzyme-treated solution, sterilized by heating at 80 ° C. for 15 minutes, and then freeze-dried and powdered. Using 57.5 mg of the excipient with respect to 192.5 mg of the obtained powder, 250 mg tablets per tablet were tableted according to a conventional method.
(錠剤6)
錠剤5の調製において、酵素処理液の固形分100質量部に対して、乾燥助剤を10質量部添加した以外は、錠剤5と同様にして、1錠あたり250mgの錠剤を得た。
(Tablet 6)
In the preparation of tablet 5, 250 mg per tablet was obtained in the same manner as tablet 5, except that 10 parts by mass of a drying aid was added to 100 parts by mass of the solid content of the enzyme-treated solution.
得られた錠剤1〜錠剤6について、その錠剤中の糖分含量(グルコースとフルクトースの合計含有量)、10−ヒドロキシ−2−デセン酸(10HDA)含有量、及び錠剤を所定環境下に保管したときの外観の変色を調べた。具体的には、糖分は、試験例1で測定した方法と同様にして測定した。10−ヒドロキシ−2−デセン酸(10HDA)は、以下に示す方法で測定した。錠剤の外観の変色は、常温、40℃、50℃の環境下(それぞれ湿度75%の環境下)に3日間保管した後の錠剤の色調を、目視により観察した。 About the obtained tablet 1 to tablet 6, when the sugar content in the tablet (total content of glucose and fructose), 10-hydroxy-2-decenoic acid (10HDA) content, and the tablet are stored in a predetermined environment The discoloration of the appearance of was examined. Specifically, the sugar content was measured in the same manner as the method measured in Test Example 1. 10-hydroxy-2-decenoic acid (10HDA) was measured by the method shown below. Regarding the discoloration of the appearance of the tablets, the color tone of the tablets after being stored for 3 days in an environment of normal temperature, 40 ° C., and 50 ° C. (an environment of 75% humidity) was visually observed.
(10HDAの含有量の測定方法)
標準品(10−ヒドロキシ−2−デセン酸:10-hydroxy-2-decenoic acid)5mgを100mL容のメスフラスコに秤量し、100%メタノールで50.0μg/mLに定容した。公比5で段階希釈し、10.0μg/mL、2.0μg/mLの標準溶液を調製した。また、各被測定検体については、その25mgを50mL容のメスフラスコに秤量し、100%メタノールで定容し、0.20μmフィルターで濾過をして分析試料とした。分析にはUPLC(超高速液体クロマトグラフ)を使用し、各被測定検体について得られた測定値曲線下面積値を、別途上記標準溶液により予め作成した検量線にあてはめ、定量した。なお、UPLC(超高速液体クロマトグラフ)の分析条件は、以下のとおりとした。
(Method for measuring the content of 10HDA)
A standard product (10-hydroxy-2-decenoic acid) (5 mg) was weighed into a 100 mL volumetric flask and fixed to 50.0 μg / mL with 100% methanol. A standard solution of 10.0 μg / mL and 2.0 μg / mL was prepared by serial dilution at a common ratio of 5. For each sample to be measured, 25 mg thereof was weighed into a 50 mL volumetric flask, fixed with 100% methanol, and filtered through a 0.20 μm filter to obtain an analysis sample. For the analysis, UPLC (ultra-high performance liquid chromatograph) was used, and the area under the measurement value curve obtained for each sample to be measured was applied to a calibration curve prepared in advance using the standard solution separately and quantified. The analysis conditions of UPLC (ultra-high performance liquid chromatograph) were as follows.
・移動相:超純水/アセトニトリル(ともに0.1%リン酸を含む)
・カラム:BEH−C18(10cm)
・流速:0.3mL/min
・検出:PDA(210nm)
・注入量:1μL
-Mobile phase: Ultrapure water / acetonitrile (both containing 0.1% phosphoric acid)
Column: BEH-C18 (10 cm)
・ Flow rate: 0.3 mL / min
・ Detection: PDA (210 nm)
・ Injection volume: 1 μL
その結果を図1に示す。 The result is shown in FIG.
図1に示すように、酵母発酵処理を施さないローヤルゼリー素材を使用して調製した錠剤1,2に比べ、酵母発酵処理を経たローヤルゼリー素材を使用して調製した錠剤3〜6では、錠剤中の糖分含量(グルコースとフルクトースの合計含有量)が顕著に減量され、40℃や50℃での加速試験における褐変が抑制された。また、乾燥助剤を使用せずに調製された錠剤1と錠剤3との比較において、酵母発酵処理を施さないローヤルゼリー素材を使用して調製した錠剤1に比べ、酵母発酵処理を経たローヤルゼリー素材を使用して調製した錠剤3では、錠剤中の10−ヒドロキシ−2−デセン酸(10HDA)含有量が相対的に増量された。よって、ローヤルゼリー含有の糖分が減量されたローヤルゼリー素材を使用することによって、錠剤全体の糖分含量が減量され、それに伴いデセン酸含有量が相対的に増量されるとともに、経時的な外観の変色(特に褐変)が抑制されることが明らかとなった。 As shown in FIG. 1, compared to tablets 1 and 2 prepared using a royal jelly material not subjected to yeast fermentation treatment, in tablets 3 to 6 prepared using a royal jelly material subjected to yeast fermentation treatment, The sugar content (total content of glucose and fructose) was significantly reduced, and browning in the accelerated test at 40 ° C. or 50 ° C. was suppressed. In addition, in comparison between tablet 1 and tablet 3 prepared without using a drying aid, royal jelly material that has undergone yeast fermentation treatment is compared to tablet 1 that has been prepared using royal jelly material that has not been subjected to yeast fermentation treatment. In tablet 3 prepared by use, the content of 10-hydroxy-2-decenoic acid (10HDA) in the tablet was relatively increased. Therefore, by using the royal jelly material in which the royal jelly-containing sugar content is reduced, the sugar content of the whole tablet is reduced, and accordingly, the decenoic acid content is relatively increased and the discoloration of the appearance over time (particularly, It became clear that browning) was suppressed.
[試験例3]
ローヤルゼリー素材においてローヤルゼリー含有の糖分を減量することによるメリットを検証するため、以下に示す粉末を準備した。
[Test Example 3]
In order to verify the merits of reducing the amount of sugar contained in the royal jelly material, the following powders were prepared.
(粉末1)
調製例5−1と同様にして調製した酵母発酵RJ末。この粉末の糖分含量(グルコースとフルクトースの合計含有量)は0質量%(測定限界以下)であった。
(Powder 1)
Yeast-fermented RJ powder prepared in the same manner as in Preparation Example 5-1. The sugar content (total content of glucose and fructose) of this powder was 0% by mass (below the measurement limit).
(粉末2)
ローヤルゼリーの凍結乾燥処理製品(アピ株式会社製)。この粉末の糖分含量(グルコースとフルクトースの合計含有量)は35.2質量%であった。
(Powder 2)
Royal jelly freeze-dried product (Api Co., Ltd.). The sugar content (total content of glucose and fructose) of this powder was 35.2% by mass.
(粉末3)
ローヤルゼリーの加熱処理製品(アピ株式会社製)。この粉末の糖分含量(グルコースとフルクトースの合計含有量)は36.4質量%であった。
(Powder 3)
Royal jelly heat treatment product (manufactured by API Corporation). The sugar content (total content of glucose and fructose) of this powder was 36.4% by mass.
(粉末4)
ローヤルゼリーの酵素処理製品(アピ株式会社製)。この粉末の糖分含量(グルコースとフルクトースの合計含有量)は26.0質量%であった。
(Powder 4)
Royal jelly enzyme treatment product (manufactured by API). The sugar content (total content of glucose and fructose) of this powder was 26.0% by mass.
上記粉末1〜粉末4について、その粉末をサンプル袋に入れ、40℃、湿度75%の環境下で保存することで加速試験を行い、経時的にサンプリングし、試料中の10−ヒドロキシ−2−デセン酸(10HDA)の含有量を測定して、その安定性を検証した。10−ヒドロキシ−2−デセン酸(10HDA)は、試験例3で測定した方法と同様にして測定した。 About the said powder 1-powder 4, the acceleration test is performed by putting the powder in a sample bag and storing it in an environment of 40 ° C. and 75% humidity, sampling over time, and 10-hydroxy-2- The content of decenoic acid (10HDA) was measured to verify its stability. 10-hydroxy-2-decenoic acid (10HDA) was measured in the same manner as the method measured in Test Example 3.
その結果を図2に示す。 The result is shown in FIG.
図2に示すように、酵母発酵処理を施さないローヤルゼリー素材である粉末2〜4に比べ、酵母発酵処理を経たローヤルゼリー素材である粉末1では、粉末中の10−ヒドロキシ−2−デセン酸(10HDA)含有量が、糖分含量の減量に伴い相対的に増量されるとともに、保存時の安定性も向上することが明らかとなった。これは、ローヤルゼリー原料に含まれる糖分その他の成分であって、デセン酸の安定性に影響を与える成分が、酵母発酵処理によって減量されたためであろうと考えられた。 As shown in FIG. 2, compared with powders 2 to 4 which are royal jelly materials not subjected to yeast fermentation treatment, powder 1 which is a royal jelly material subjected to yeast fermentation treatment has 10-hydroxy-2-decenoic acid (10HDA) in the powder. ) It has been clarified that the content is relatively increased as the sugar content is reduced, and the stability during storage is also improved. This was thought to be because sugars and other components contained in the royal jelly raw material, which affect the stability of decenoic acid, were reduced by the yeast fermentation treatment.
[試験例4]
発酵処理のための酵母として酵母含有製剤Eを使用した調製例5−1において、酵母発酵処理するRJ溶液の乾燥固形分換算含量を2.6、5.1、7.7、11質量%と変え、更にpH条件をpH4〜7の範囲で変えて、それ以外は調製例5−1と同様にして、それぞれの条件における酵母発酵RJ末を調製し、試験例1と同様にして、それらの糖分含量(グルコースとフルクトースの合計含有量)を求めた。なお、それぞれのpH条件において、RJ溶液の乾燥固形分換算含量を10質量%に調整した場合であって、酵母を添加直後に殺菌を行い、酵母発酵処理を施さないで調製例5−1と同様にして調製したRJ末についても、対照として、同様にそれらの糖分含量(グルコースとフルクトースの合計含有量)を求めた。
[Test Example 4]
In Preparation Example 5-1, in which the yeast-containing preparation E was used as the yeast for fermentation treatment, the dry solid content equivalent content of the RJ solution to be subjected to yeast fermentation was 2.6, 5.1, 7.7, and 11% by mass. In addition, the pH conditions were changed in the range of pH 4-7, and other than that, preparation of yeast fermentation RJ powder in each condition was prepared in the same manner as in Preparation Example 5-1, and in the same manner as in Test Example 1, those The sugar content (total content of glucose and fructose) was determined. In addition, in each pH condition, it is a case where the dry solid content conversion content of RJ solution is adjusted to 10% by mass, and sterilization is performed immediately after the addition of yeast, and the yeast fermentation treatment is not performed. For the RJ powder prepared in the same manner, the sugar content (the total content of glucose and fructose) was similarly determined as a control.
その結果を表3に示す。 The results are shown in Table 3.
その結果、表3に示すように、液状基質たるRJ溶液のpHをpH5.0から酸性側に調整して酵母発酵処理を行なった場合、ローヤルゼリー含有の糖分はほとんど減量されなかった。また、液状基質たるRJ溶液のpHをpH6.0に調整して酵母発酵処理を行なうと、RJ溶液の乾燥固形分含量が5.1質量%以下の場合には、ローヤルゼリー含有の糖分はほぼ消失したが、RJ溶液の乾燥固形分含量が7.7質量%の場合には、ローヤルゼリー含有の糖分は半分程度残存し、RJ溶液の乾燥固形分含量が11質量%の場合には、ローヤルゼリー含有の糖分はほとんど減量されなかった。一方、液状基質たるRJ溶液のpHをpH7.0に調整して酵母発酵処理を行なうと、RJ溶液の乾燥固形分含量が2.6〜11質量%の範囲で、いずれの場合においても、ローヤルゼリー含有の糖分はほぼ消失した。よって、ローヤルゼリー含有の糖分を効率よく減量するには、pHと固形分含量の両方のファクターが重要であることが明らかとなった。 As a result, as shown in Table 3, when the pH of the RJ solution as a liquid substrate was adjusted from pH 5.0 to the acidic side and the yeast fermentation treatment was performed, the royal jelly-containing sugar content was hardly reduced. In addition, when yeast fermentation treatment is performed by adjusting the pH of the RJ solution, which is a liquid substrate, to pH 6.0, when the dry solid content of the RJ solution is 5.1 mass% or less, the royal jelly-containing sugar content is almost lost. However, when the dry solid content of the RJ solution is 7.7% by mass, about half of the royal jelly-containing sugar remains, and when the dry solid content of the RJ solution is 11% by mass, the royal jelly-containing sugar content remains. The sugar content was hardly reduced. On the other hand, when the yeast fermentation treatment is performed by adjusting the pH of the RJ solution, which is a liquid substrate, to pH 7.0, the dry solid content of the RJ solution is in the range of 2.6 to 11% by mass. The contained sugar was almost lost. Therefore, it has been clarified that both the pH and the solid content factors are important for efficiently reducing the sugar content of royal jelly.
[試験例5]
発酵処理のための酵母として酵母含有製剤Eを使用した調製例5−1において、酵母発酵処理するRJ溶液の乾燥固形分換算含量を、下記表4に示すとおりに2.6〜30質量%の範囲で変え、更にpH条件をpH5.5〜12の範囲で変えて、それ以外は調製例5−1と同様にして、それぞれの条件における酵母発酵RJ末を調製した。なお、酵母発酵処理の時間は、基本的には調製例5−1と同様に24時間とし(下記表4では「1d」で示される。)、RJ溶液の乾燥固形分換算含量を25又は30質量%に調製した場合にあっては、更に3日間(下記表4中「3d」で示される。)、5日間(下記表4では「5d」で示される。)、又は7日間(下記表4では「7d」で示される。)の処理時間についても酵母発酵RJ末を調製した。得られた酵母発酵RJ末について、試験例1と同様にして、それらの糖分含量(グルコースとフルクトースの合計含有量、ないしはグルコースとフルクトースとスクロースの合計含有量)を求めた。また、試験例2と同様にして、それらの10−ヒドロキシ−2−デセン酸(10HDA)の含有量を求めた。また、以下に示す方法で、それらの蛋白質及び/又はペプチドの含有量を求めた。なお、それぞれのpH条件において、RJ溶液の乾燥固形分換算含量を11、22、25、又は30質量%に調整した場合であって、酵母を添加直後に殺菌を行い、酵母発酵処理を施さないで調製例5−1と同様にして調製したRJ末についても、対照として(下記表4では「N」で示される。)、同様にそれらの糖分含量(グルコースとフルクトースの合計含有量、ないしはグルコースとフルクトースとスクロースの合計含有量)、10−ヒドロキシ−2−デセン酸(10HDA)の含有量、及び蛋白質及び/又はペプチドの含有量を求めた。
[Test Example 5]
In Preparation Example 5-1, in which the yeast-containing preparation E was used as the yeast for fermentation treatment, the dry solid content equivalent content of the RJ solution to be subjected to yeast fermentation was 2.6 to 30% by mass as shown in Table 4 below. The yeast fermentation RJ powder under each condition was prepared in the same manner as in Preparation Example 5-1, except that the pH conditions were changed within the range and the pH conditions were changed within the range of pH 5.5 to 12. The yeast fermentation treatment time is basically 24 hours as in Preparation Example 5-1 (indicated by “1d” in Table 4 below), and the dry solid content equivalent of the RJ solution is 25 or 30. In the case of adjusting to the mass%, it is further 3 days (indicated by “3d” in the following Table 4), 5 days (indicated by “5d” in the following Table 4), or 7 days (in the following Table). In FIG. 4, the yeast fermentation RJ powder was also prepared for the treatment time of “7d”. About the obtained yeast fermentation RJ powder | flour, it carried out similarly to Experiment 1, and calculated | required those sugar content (The total content of glucose and fructose, or the total content of glucose, fructose, and sucrose). Further, the content of 10-hydroxy-2-decenoic acid (10HDA) was determined in the same manner as in Test Example 2. Moreover, the content of those proteins and / or peptides was determined by the method shown below. In addition, in each pH condition, it is a case where the dry solid content conversion content of RJ solution is adjusted to 11, 22, 25, or 30 mass%, Comprising: It sterilizes immediately after adding yeast, and does not give a yeast fermentation process. RJ powder prepared in the same manner as in Preparation Example 5-1 was also used as a control (indicated by “N” in Table 4 below), and similarly, their sugar content (total content of glucose and fructose, or glucose , Fructose and sucrose total content), 10-hydroxy-2-decenoic acid (10HDA) content, and protein and / or peptide content.
(蛋白質・ペプチドの含有量の測定方法)
標準品(ウシ血清アルブミン:BSA)20mgを10mL容のメスフラスコに秤量し、超純水で2.00mg/mLに定容した。その後、公比2で段階希釈し、1.00mg/mL〜0.03mg/mLの標準溶液を調製した。また、各被測定検体については、その5mgを15mL容の遠沈管に秤量し、2.5%SDS水溶液を5mL加えたうえ、95℃で10分間加熱した後、3000rpmで、5分間後遠心分離して、得られた上清を分析試料とした。分析には、蛋白質・ペプチド用定量キット(「BCA Protein assay kit」Thermo Fisher Scientific社)を使用し、キットの添付プロトコールに従い、プレートリーダーにて562nmの吸光度を測定した。別途上記標準溶液により予め作成した検量線にあてはめ、定量した。
(Method for measuring protein / peptide content)
20 mg of a standard product (bovine serum albumin: BSA) was weighed into a 10 mL volumetric flask, and the volume was adjusted to 2.00 mg / mL with ultrapure water. Thereafter, serial dilution was performed at a common ratio of 2 to prepare a standard solution of 1.00 mg / mL to 0.03 mg / mL. For each sample to be measured, 5 mg of the sample was weighed into a 15 mL centrifuge tube, 5 mL of 2.5% SDS aqueous solution was added, heated at 95 ° C. for 10 minutes, and then centrifuged at 3000 rpm for 5 minutes. The obtained supernatant was used as an analysis sample. For the analysis, a protein / peptide quantitative kit (“BCA Protein assay kit” Thermo Fisher Scientific) was used, and the absorbance at 562 nm was measured with a plate reader according to the protocol attached to the kit. Separately, it was applied to a calibration curve prepared in advance using the standard solution, and quantified.
その結果を表4に示す。 The results are shown in Table 4.
その結果、表4に示すように、液状基質たるRJ溶液のpHがpH5.5〜11の範囲において、ローヤルゼリー含有の糖分を減量する効果や10−ヒドロキシ−2−デセン酸(10HDA)の増量効果が認められた。更には、蛋白質及び又はペプチドについても、増量効果が認められた。また、液状基質たるRJ溶液の乾燥固形分含量が2.6〜30質量%の範囲において、ローヤルゼリー含有の糖分を減量する効果や10−ヒドロキシ−2−デセン酸(10HDA)の増量効果が認められた。更には、蛋白質及び又はペプチドについても、増量効果が認められた。ただし、液状基質たるRJ溶液の乾燥固形分含量が25質量%や30質量%の場合には、本試験例の条件においては、処理に時間を要した。一方、液状基質たるRJ溶液のpHをpH12に調整して酵母発酵処理を行なうと、液状基質たるRJ溶液の乾燥固形分含量が11質量%の場合であっても、ローヤルゼリー含有の糖分を減量する効果は得られなかった。よって、試験例4の結果同様に、ローヤルゼリー含有の糖分を効率よく減量するには、pHと固形分含量の両方のファクターが重要であることが明らかとなった。 As a result, as shown in Table 4, when the pH of the RJ solution as the liquid substrate is in the range of pH 5.5 to 11, the effect of reducing the amount of sugar contained in the royal jelly and the effect of increasing the amount of 10-hydroxy-2-decenoic acid (10HDA) Was recognized. Furthermore, the effect of increasing the amount was also observed for proteins and / or peptides. In addition, when the dry solid content of the RJ solution as the liquid substrate is in the range of 2.6 to 30% by mass, the effect of reducing the sugar content of royal jelly and the effect of increasing the amount of 10-hydroxy-2-decenoic acid (10HDA) are recognized. It was. Furthermore, the effect of increasing the amount was also observed for proteins and / or peptides. However, when the dry solid content of the RJ solution, which is a liquid substrate, was 25% by mass or 30% by mass, the treatment took time under the conditions of this test example. On the other hand, when the yeast fermentation treatment is performed by adjusting the pH of the RJ solution, which is a liquid substrate, to pH 12, even if the dry solid content of the RJ solution, which is a liquid substrate, is 11% by mass, the amount of sugar contained in the royal jelly is reduced. The effect was not obtained. Therefore, as in the results of Test Example 4, it was revealed that both the pH and solid content factors are important for efficiently reducing the royal jelly-containing sugar content.
[試験例6]
特開2006−219434号公報に記載された発明と、本発明の相異を検証するため、以下に示す検体を調製した。
[Test Example 6]
In order to verify the difference between the invention described in JP-A-2006-219434 and the present invention, the following specimens were prepared.
(検体1)
特開2006−219434号公報の製造例4と同様にしてローヤルゼリーの酵母発酵物を調製した。
(Sample 1)
A royal jelly yeast fermentation product was prepared in the same manner as in Production Example 4 of JP-A-2006-219434.
具体的には、ローヤルゼリーの凍結乾燥製品(アピ株式会社製)を使用し、その凍結乾燥ローヤルゼリー粉末30gに、蒸留水970gを加えて懸濁液を調製し、加熱殺菌した。この懸濁液にグルコアミラーゼ0.3g、パパイン0.3g、及びペクチナーゼ0.3gを加えた後、市販のパン酵母含有製剤Eを酵母菌数が108個/mLとなるように接種し、37℃で3日間静置培養した。培養終了後培養液を加熱殺菌し、その後に凍結乾燥して、これを検体1のRJ末とした。 Specifically, a royal jelly freeze-dried product (manufactured by API Co., Ltd.) was used, and a suspension was prepared by adding 970 g of distilled water to 30 g of the freeze-dried royal jelly powder, followed by heat sterilization. After adding 0.3 g of glucoamylase, 0.3 g of papain, and 0.3 g of pectinase to this suspension, a commercially available baker's yeast-containing preparation E was inoculated so that the number of yeasts was 10 8 / mL, The culture was stationary at 37 ° C. for 3 days. After completion of the culture, the culture broth was sterilized by heating, and then freeze-dried to obtain the RJ powder of Sample 1.
(検体2)
特開2006−219434号公報の製造例9と同様にしてローヤルゼリーの酵母発酵物を調製した。
(Sample 2)
Royal jelly fermented yeast was prepared in the same manner as in Production Example 9 of JP-A-2006-219434.
具体的には、ローヤルゼリーの凍結乾燥製品(アピ株式会社製)を使用し、その凍結乾燥ローヤルゼリー粉末30gに、蒸留水970gを加えて懸濁液を調製し、加熱殺菌した。この懸濁液に市販のパン酵母含有製剤Eを酵母菌数が108個/mLとなるように接種し、37℃で3日間静置培養した。培養終了後培養液を加熱殺菌し、その後に凍結乾燥して、これを検体2のRJ末とした。 Specifically, a royal jelly freeze-dried product (manufactured by API Co., Ltd.) was used, and a suspension was prepared by adding 970 g of distilled water to 30 g of the freeze-dried royal jelly powder, followed by heat sterilization. This suspension was inoculated with a commercially available baker's yeast-containing preparation E so that the number of yeasts was 10 8 / mL, and left to stand at 37 ° C. for 3 days. After completion of the culture, the culture broth was sterilized by heating, and then freeze-dried. This was used as the RJ powder of Sample 2.
(検体3)
検体1の調製において、酵母を接種する前の懸濁液に添加したグルコアミラーゼ、パパイン、及びペクチナーゼを、いずれも加熱失活させて使用し、その後接種する酵母含有製剤Eも加熱失活させて使用した以外は、上記検体1と同様にして、検体3のRJ末を調製した。
(Sample 3)
In the preparation of specimen 1, glucoamylase, papain, and pectinase added to the suspension before inoculation with yeast are all used after being heat-inactivated, and then yeast-containing preparation E to be inoculated is also heat-inactivated. The RJ powder of Sample 3 was prepared in the same manner as Sample 1 except that it was used.
(検体4)
検体2の調製において、酵母含有製剤Eを加熱失活させて使用した以外は、上記検体2と同様にして、検体4のRJ末を調製した。
(Sample 4)
In the preparation of Sample 2, the RJ powder of Sample 4 was prepared in the same manner as Sample 2 except that yeast-containing preparation E was used after being heat-inactivated.
(検体5)
検体2の調製において、酵母を接種する懸濁液のpHを6Nの水酸化ナトリウム水溶液を用いてpHを7.0に調整した以外は、上記検体2と同様にして、検体5のRJ末を調製した。
(Sample 5)
In the preparation of Sample 2, the RJ end of Sample 5 was changed in the same manner as Sample 2 except that the pH of the suspension inoculated with yeast was adjusted to 7.0 using a 6N aqueous sodium hydroxide solution. Prepared.
得られた検体1〜検体5について、その粉末中のグルコース、フルクトース、及びスクロースの含有量を、試験例1で測定した方法と同様にして測定した。なお、比較のために、原料としたローヤルゼリーの凍結乾燥製品についても、同様に、糖分含量を測定した。 About the obtained sample 1-sample 5, the content of glucose, fructose, and sucrose in the powder was measured in the same manner as the method measured in Test Example 1. For comparison, the sugar content of the royal jelly lyophilized product as a raw material was also measured.
その結果を表5に示す。 The results are shown in Table 5.
その結果、表5に示すように、特開2006−219434号公報の製造例4と同様にして調製した検体1のRJ末や、同製造例9と同様にして調製した検体2のRJ末では、酵素や酵母を加熱失活させて添加して調製した検体3のRJ末や、酵素処理を施さずに酵母を加熱失活させて添加して調製した検体4のRJ末に比べて、糖分の減量がほとんど認められなかった。これに対して、酵母を接種する際の懸濁液のpHをpH7.0に調整して調製した検体5のRJ末では、糖分の減量が顕著であった。よって、特開2006−219434号公報に記載された酵母発酵物では、糖分の減量化が本発明のようには十分になされておらずに、その原因の1つにはpH条件の不適合が挙げられるのではないかと考えられた。 As a result, as shown in Table 5, the RJ powder of Sample 1 prepared in the same manner as in Production Example 4 of JP-A-2006-219434 and the RJ powder of Sample 2 prepared in the same manner as in Production Example 9 Compared to the RJ powder of Sample 3 prepared by adding enzyme and yeast after heat-inactivation, and the RJ powder of Sample 4 prepared by adding heat-inactivated yeast without enzyme treatment, Almost no weight loss was observed. On the other hand, in the RJ powder of Sample 5 prepared by adjusting the pH of the suspension at the time of inoculation with yeast to pH 7.0, the sugar content was significantly reduced. Therefore, in the yeast fermented product described in Japanese Patent Application Laid-Open No. 2006-219434, the sugar content is not sufficiently reduced as in the present invention, and one of the causes is incompatibility of pH conditions. It was thought that it was possible.
[試験例7]
ローヤルゼリー素材においてローヤルゼリー含有の糖分を減量することによるメリットを検証するため、以下に示すようにして検体を調製した。
[Test Example 7]
In order to verify the merit of reducing the amount of sugar contained in the royal jelly material, a specimen was prepared as follows.
<A>ローヤルゼリーの酵母発酵処理
固形分30質量%の生ローヤルゼリーの3.95kgに対して超純水8.00kgを加えて、これを攪拌して成分をよく溶解・分散させるとともに、20%水酸化ナトリウム水溶液を用いてpHを7.0に調整した(乾燥固形分含量:約10質量%)。このローヤルゼリー溶液(RJ溶液)の約12.2kgに対して、市販のパン酵母含有製剤E60gを添加し(RJ溶液の固形分の5%)、好気条件下に30℃で48時間インキュベートすることにより、酵母発酵処理を行なった。酵母発酵処理後には、60℃達温後に30分間維持して加熱殺菌した。このようにして得られたローヤルゼリーの酵母発酵処理液を、以下「FY−RJ溶液」と称する場合がある。
上記FY−RJ溶液の糖分含量(グルコース、フルクトース、及びスクロース)を試験例1と同様にして測定したところ、いずれも検出限界以下の含有量であり、ローヤルゼリー含有の糖分は著しく減量していた。
上記FY−RJ溶液に対して、後述の表6に示す乾燥助剤をそれぞれ、乾燥固形分換算にして15質量%の量となるように添加し、よく混合したうえ、ディスポーザブルアルミ角皿に20g程度分注し、棚式凍結乾燥器にて凍結乾燥した。乾燥温度は35℃とし、乾燥時間は3日とした。また、コントロールとして、乾燥助剤を添加していないFY−RJ溶液も同様に凍結乾燥した。なお、乾燥助剤として増粘性のあるペクチン、アルギン酸ナトリウム、ローカストビーンガムを使用する場合については、それぞれを乾燥固形分換算にして5質量%の量となるように添加したうえ、更に微結晶セルロースを併用して、これを10質量%の量となるように添加した。
得られたブロック状の凍結乾燥物を卓上ミルで粉砕し、検体とした。
<A> Yeast fermentation treatment of royal jelly
Add 8.00 kg of ultrapure water to 3.95 kg of raw royal jelly with a solid content of 30% by weight, stir this to dissolve and disperse the components well, and adjust the pH using 20% aqueous sodium hydroxide solution. It was adjusted to 7.0 (dry solid content: about 10% by mass). To about 12.2 kg of this royal jelly solution (RJ solution), add commercially available baker's yeast-containing preparation E60 g (5% solid content of RJ solution) and incubate at 30 ° C. for 48 hours under aerobic conditions. The yeast fermentation process was performed. After the yeast fermentation treatment, it was sterilized by heating for 30 minutes after reaching 60 ° C. The royal jelly yeast fermentation treatment solution thus obtained may be hereinafter referred to as “FY-RJ solution”.
When the sugar content (glucose, fructose, and sucrose) of the FY-RJ solution was measured in the same manner as in Test Example 1, all of them were below the detection limit, and the royal jelly-containing sugar content was significantly reduced.
To the above-mentioned FY-RJ solution, each of the drying aids shown in Table 6 to be described later is added so as to have an amount of 15% by mass in terms of dry solid content, mixed well, and 20 g in a disposable aluminum square dish. The aliquot was dispensed and lyophilized with a shelf-type lyophilizer. The drying temperature was 35 ° C. and the drying time was 3 days. As a control, the FY-RJ solution to which no drying aid was added was freeze-dried in the same manner. In addition, when using thickened pectin, sodium alginate, and locust bean gum as a drying aid, each was added to a dry solid content equivalent to 5% by mass, and further microcrystalline cellulose. Was added in combination so that the amount was 10% by mass.
The obtained block-shaped freeze-dried product was pulverized with a table mill to prepare a specimen.
<B>ローヤルゼリー溶液(非処理)
上記<A>で使用した固形分30質量%の生ローヤルゼリーの4.00kgに対して超純水8.00kgを加えて、これを攪拌して成分をよく溶解・分散させ、乾燥固形分含量約10.92質量%のローヤルゼリー溶液(RJ溶液)を得、この非処理のローヤルゼリー溶液に対して、上記<A>で行ったのと同様にして、後述の表6に示す乾燥助剤をそれぞれ添加したうえ、凍結乾燥物を得た。得られたブロック状の凍結乾燥物を卓上ミルで粉砕し、検体とした。
なお、上記RJ溶液の糖分含量(グルコース、フルクトース、及びスクロース)を試験例1と同様にして測定したところ、それぞれの乾燥固形分換算質量は、グルコースで13.86質量%であり、フルクトースで13.22質量%であり、スクロースで0.97質量%の含有量であった。
<B> Royal jelly solution (untreated)
Add 4.00 kg of ultrapure water to 4.00 kg of the raw royal jelly having a solid content of 30% by mass used in the above <A>, and stir this to dissolve and disperse the components well. A 10.92 mass% royal jelly solution (RJ solution) was obtained, and the drying aids shown in Table 6 to be described later were added to the untreated royal jelly solution in the same manner as in <A> above. In addition, a lyophilized product was obtained. The obtained block-shaped freeze-dried product was pulverized with a table mill to prepare a specimen.
In addition, when the sugar content (glucose, fructose, and sucrose) of the RJ solution was measured in the same manner as in Test Example 1, the mass in terms of dry solid content was 13.86% by mass for glucose and 13% for fructose. The sucrose content was 0.97% by mass.
<C>ローヤルゼリー酵母発酵液の酵素処理
上記<A>で調製したFY−RJ溶液の4.75kgに20%水酸化ナトリウム水溶液を加えてpHを8.75に調整したうえ、蛋白質分解酵素製剤(「スミチームFP−G」新日本化学工業株式会社製)の4.96gを添加し(FY−RJ溶液の固形分の1%)、50℃で3時間、酵素処理を行なった。酵素処理後には、78℃達温後に15分間維持して失活処理した。このようにして得られたローヤルゼリー酵母発酵液の酵素処理液に対して、上記<A>で行ったのと同様にして、後述の表6に示す乾燥助剤をそれぞれ添加したうえ、凍結乾燥物を得た。得られたブロック状の凍結乾燥物を卓上ミルで粉砕し、検体とした。
<C> Enzymatic treatment of royal jelly yeast fermentation broth
After adding 20% aqueous sodium hydroxide solution to 4.75 kg of the FY-RJ solution prepared in <A> above to adjust the pH to 8.75, a proteolytic enzyme preparation (“Sumiteam FP-G” Shin Nippon Chemical Industry Co., Ltd.) 4.96 g (manufactured by Co., Ltd.) was added (1% solid content of FY-RJ solution), and the enzyme treatment was performed at 50 ° C. for 3 hours. After the enzyme treatment, it was inactivated by maintaining for 15 minutes after reaching 78 ° C. In the same manner as in <A> above, the drying aid shown in Table 6 to be described later was added to the enzyme treatment solution of the royal jelly yeast fermentation broth thus obtained, and then the freeze-dried product. Got. The obtained block-shaped freeze-dried product was pulverized with a table mill to prepare a specimen.
<D>ローヤルゼリー溶液の酵素処理
上記<B>で調製したRJ溶液の6.00kgに20%水酸化ナトリウム水溶液を加えてpHを8.74に調整したうえ、蛋白質分解酵素製剤(「スミチームFP−G」新日本化学工業株式会社製)の6.56gを添加し(RJ溶液の固形分の1%)、50℃で3時間、酵素処理を行なった。酵素処理後には、80℃達温後に15分間維持して失活処理した。このようにして得られたローヤルゼリー溶液の酵素処理液に対して、上記<A>で行ったのと同様にして、後述の表6に示す乾燥助剤をそれぞれ添加したうえ、凍結乾燥物を得た。得られたブロック状の凍結乾燥物を卓上ミルで粉砕し、検体とした。
<D> Enzymatic treatment of royal jelly solution
After adding 20% sodium hydroxide aqueous solution to 6.00 kg of the RJ solution prepared in the above <B> to adjust the pH to 8.74, a proteolytic enzyme preparation (“Sumiteam FP-G” Shin Nippon Chemical Industry Co., Ltd.) (1% solid content of RJ solution) was added, and the enzyme treatment was performed at 50 ° C. for 3 hours. After the enzyme treatment, it was inactivated by maintaining for 15 minutes after reaching 80 ° C. To the enzyme treatment solution of the royal jelly solution thus obtained, in the same manner as in <A> above, drying aids shown in Table 6 described later were added, and a lyophilized product was obtained. It was. The obtained block-shaped freeze-dried product was pulverized with a table mill to prepare a specimen.
表6には、上記の検体の調製に使用した乾燥助剤の情報とともに、各乾燥助剤ごとに付したサンプル名をまとめて示す。 Table 6 summarizes the names of the samples given for each drying aid together with the information on the drying aid used for the preparation of the specimen.
[評価1]
(1)苛酷試験による色調の変化
50℃での苛酷試験を行って、その際の粉末の色調の変化を調べた。具体的には、サンプルRJ粉末を約10gずつ樹脂フィルムからなるジップ容器に入れ、封を閉じて容器ごと50℃の恒温器に入れた。苛酷試験開始前と、開始1日後、3日後、7日後、14日後に写真撮影と色差測定を行った。
[Evaluation 1]
(1) Change in color tone by severe test A severe test at 50 ° C was conducted to examine the change in color tone of the powder. Specifically, about 10 g of sample RJ powder was placed in a zip container made of a resin film, the seal was closed, and the entire container was placed in a thermostat at 50 ° C. Photographing and color difference measurement were performed before the start of the severe test and after 1 day, 3 days, 7 days, and 14 days.
色差測定には色差計(ZE-2000、NIPPON DENSHOKU)を使用し、CIE(国際照明委員会)L*a*b*色空間表示系におけるa*値、b*値、L*値を測定し、下記式(1)によってRJ粉末の色差(ΔEi)を算出した(n=3)。 For color difference measurement, a color difference meter (ZE-2000, NIPPON DENSHOKU) is used to measure the a * value, b * value, and L * value in the CIE (International Lighting Commission) L * a * b * color space display system. The color difference (ΔE i ) of the RJ powder was calculated by the following formula (1) (n = 3).
ΔEi={(Li−L0)2+(ai−a0)2+(bi−b0)2}1/2・・・(1)
(式中、L0、a0、及びb0は、それぞれ苛酷試験開始前におけるRJ粉末のL*値、a*値、及びb*値であり、Li、ai、及びbiは、それぞれ苛酷試験後におけるRJ粉末のL*値、a*値、及びb*値である。)
ΔE i = {(L i −L 0 ) 2 + (a i −a 0 ) 2 + (b i −b 0 ) 2 } 1/2 (1)
(In the formula, L 0 , a 0 , and b 0 are the L * value, a * value, and b * value of the RJ powder before the start of the severe test, respectively, and L i , a i , and b i are (The L * value, a * value, and b * value of the RJ powder after the severe test, respectively.)
写真撮影の結果を図3〜図10に、色差測定の結果を表7に、それぞれ示す。また、図11及び図12には、色差測定の結果をグラフ化して示す。 3 to 10 show the results of photography, and Table 7 shows the results of color difference measurement. Moreover, in FIG.11 and FIG.12, the result of a color difference measurement is graphed and shown.
その結果、特に、図11にグラフ化して示されるように、ローヤルゼリーに酵母発酵処理を施して調製したRJ粉末(A0〜A16のサンプル)は、酵母発酵処理を施さないで調製したRJ粉末(B0〜B16のサンプル)に比べ、苛酷試験における経時的な外観の変色(特に褐変)が抑制された。また、図12にグラフ化して示されるように、ローヤルゼリーに酵母発酵処理と酵素処理を施して調製したRJ粉末(C0〜C16のサンプル)は、ローヤルゼリーに酵素処理を施したが、酵母発酵処理を施さないで調製したRJ粉末(D0〜D16のサンプル)に比べ、苛酷試験における経時的な外観の変色(特に褐変)が抑制された。このような変色抑制効果は、酵母発酵処理が施されたことにより糖分が減量し、メーラード反応や酸化反応等の変色に関わる反応が抑制されたことが1つの原因として考えられた。 As a result, in particular, as shown in the graph of FIG. 11, RJ powder (samples A0 to A16) prepared by subjecting royal jelly to yeast fermentation treatment was prepared without performing yeast fermentation treatment (B0). As compared with the sample of B16), discoloration of the appearance over time in the severe test (particularly browning) was suppressed. In addition, as shown in the graph of FIG. 12, RJ powder (C0-C16 sample) prepared by subjecting royal jelly to yeast fermentation treatment and enzyme treatment was applied to royal jelly with enzyme fermentation treatment. Compared to the RJ powder (samples D0 to D16) prepared without application, discoloration of the appearance over time in the severe test (particularly browning) was suppressed. Such a discoloration suppressing effect was thought to be caused by the fact that the sugar content was reduced by the yeast fermentation treatment, and the reactions related to discoloration such as Maillard reaction and oxidation reaction were suppressed.
また、サンプルA5(デキストリンDE3)、A1(ヒドロキシプロピルデンプン)、A2(α化デンプン)、A16(還元デンプン分解物)、A7(γ-シクロデキストリン)、A8(α-シクロデキストリン)、A10(アルギン酸ナトリウム)、A14(キトサン)、A11(イヌリン)、A12(ローカストビーンガム)、A13(微結晶セルロース)、A15(ゼラチン)、C4(デキストリンDE11)、C5(デキストリンDE3)、C1(ヒドロキシプロピルデンプン)、C2(α化デンプン)、C16(還元デンプン分解物)、C6(クラスターデキストリン)、C7(γ-シクロデキストリン)、C8(α-シクロデキストリン)、C10(アルギン酸ナトリウム)、C14(キトサン)、C11(イヌリン)、C12(ローカストビーンガム)、C15(ゼラチン)の結果にみられるように、それぞれに使用された乾燥助剤、デキストリン(DE3)、デキストリン(DE11)、ヒドロキシプロピルデンプン、α化デンプン、還元デンプン分解物、γ-シクロデキストリン、α-シクロデキストリン、アルギン酸ナトリウム、キトサン、イヌリン、ローカストビーンガム、微結晶セルロース、ゼラチン、クラスターデキストリンによって、酵母発酵処理による変色抑制効果は、更に増長された。一方で、サンプルA3、A9、C3、C9の結果にみられるように、それぞれに使用された乾燥助剤、デキストリン(DE25)、ペクチンは、かえって酵母発酵処理による変色抑制効果を打ち消してしまう結果となった。 Sample A5 (dextrin DE3), A1 (hydroxypropyl starch), A2 (pregelatinized starch), A16 (reduced starch degradation product), A7 (γ-cyclodextrin), A8 (α-cyclodextrin), A10 (alginic acid) Sodium), A14 (chitosan), A11 (inulin), A12 (locust bean gum), A13 (microcrystalline cellulose), A15 (gelatin), C4 (dextrin DE11), C5 (dextrin DE3), C1 (hydroxypropyl starch) , C2 (pregelatinized starch), C16 (reduced starch degradation product), C6 (cluster dextrin), C7 (γ-cyclodextrin), C8 (α-cyclodextrin), C10 (sodium alginate), C14 (chitosan), C11 (Inulin), C12 (Locus) Tobein gum), C15 (gelatin), as seen in the results of drying aid, dextrin (DE3), dextrin (DE11), hydroxypropyl starch, pregelatinized starch, reduced starch degradation product, γ-cyclo By using dextrin, α-cyclodextrin, sodium alginate, chitosan, inulin, locust bean gum, microcrystalline cellulose, gelatin, and cluster dextrin, the effect of inhibiting discoloration by yeast fermentation treatment was further increased. On the other hand, as seen in the results of samples A3, A9, C3, and C9, the drying aid, dextrin (DE25), and pectin used for each of the results cancel the discoloration suppressing effect by the yeast fermentation treatment. became.
[評価2]
(2)苛酷試験による凝集状態の変化
上記(1)と同様にして50℃での苛酷試験を行って、その際の粉末の凝集状態の変化を調べた。具体的には、下記の基準で評価した。
[Evaluation 2]
(2) Change in Aggregation State by Severe Test A severe test at 50 ° C. was performed in the same manner as in (1) above, and changes in the aggregation state of the powder at that time were examined. Specifically, the evaluation was performed according to the following criteria.
(スコア基準)
0 - 凝集がまったく認められない
1 * ごく僅かに凝集が認められるが、流動しただけで崩壊する程度
2 ** 凝集物の長径が4mm未満の凝集が多数認められる
3 *** 凝集物の長径が4mm以上8mm未満の凝集が多数認められる
4 **** 凝集物の長径が8mm以上の凝集が認められる
5 ***** 完全に固化している
(Score basis)
0-No agglomeration is observed 1 * Only a little agglomeration is observed, but it disintegrates only by flowing 2 ** Many agglomerates with a major axis of less than 4 mm are observed 3 *** Major axis of aggregate 4 **** Aggregation of 4 mm or more and less than 8 mm is observed 4 **** Aggregation of the aggregate whose major axis is 8 mm or more is observed 5 ***** Completely solidified
結果は、表8にまとめた。 The results are summarized in Table 8.
その結果、上記表8−1及び表8−3に示した結果にみられるように、ローヤルゼリーに酵母発酵処理を施して調製したRJ粉末(A0〜A16のサンプル)は、酵母発酵処理を施さないで調製したRJ粉末(B0〜B16のサンプル)に比べ、苛酷試験における粉末の凝集が抑制された。また、上記表8−2及び表8−4に示した結果にみられるように、ローヤルゼリーに酵母発酵処理と酵素処理を施して調製したRJ粉末(C0〜C16のサンプル)は、ローヤルゼリーに酵素処理を施したが、酵母発酵処理を施さないで調製したRJ粉末(D0〜D16のサンプル)に比べ、苛酷試験における粉末の凝集が抑制された。このような凝集抑制効果は、酵母発酵処理が施されたことにより糖分が減量し、RJ粉末を構成する粒子どうしの結着に関わる性質が変化したことが1つの原因として考えられた。 As a result, as seen in the results shown in Table 8-1 and Table 8-3, the RJ powder (samples A0 to A16) prepared by subjecting royal jelly to yeast fermentation treatment does not undergo yeast fermentation treatment. Compared with the RJ powder (samples B0 to B16) prepared in step 1, the aggregation of the powder in the severe test was suppressed. Moreover, as seen in the results shown in Table 8-2 and Table 8-4 above, RJ powder (samples C0 to C16) prepared by subjecting royal jelly to yeast fermentation treatment and enzyme treatment was treated with royal jelly to enzyme treatment. However, agglomeration of the powder in the severe test was suppressed as compared with the RJ powder (samples D0 to D16) prepared without the yeast fermentation treatment. Such a coagulation inhibitory effect was thought to be caused by the fact that the sugar content was reduced by the yeast fermentation treatment, and the properties related to the binding of the particles constituting the RJ powder were changed.
なお、サンプルA3、A4、A6の結果にみられるように、それぞれに使用された乾燥助剤、デキストリン(DE25)、デキストリン(DE11)、クラスターデキストリンにより、かえって酵母発酵処理による粉末の凝集抑制効果が打ち消される結果となった。 In addition, as seen in the results of samples A3, A4, and A6, the drying aid, dextrin (DE25), dextrin (DE11), and cluster dextrin used for each of them exhibited a powder aggregation suppression effect by yeast fermentation treatment. The result was countered.
Claims (10)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016254419 | 2016-12-27 | ||
| JP2016254419 | 2016-12-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017243972A Division JP6985666B2 (en) | 2016-12-27 | 2017-12-20 | Manufacturing method of royal jelly material, royal jelly material, food and drink containing royal jelly, and cosmetics containing royal jelly |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018108116A true JP2018108116A (en) | 2018-07-12 |
| JP7057939B2 JP7057939B2 (en) | 2022-04-21 |
Family
ID=62785555
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017243972A Active JP6985666B2 (en) | 2016-12-27 | 2017-12-20 | Manufacturing method of royal jelly material, royal jelly material, food and drink containing royal jelly, and cosmetics containing royal jelly |
| JP2018071633A Active JP7057939B2 (en) | 2016-12-27 | 2018-04-03 | Manufacturing method of royal jelly material, royal jelly material, food and drink containing royal jelly, and cosmetics containing royal jelly |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017243972A Active JP6985666B2 (en) | 2016-12-27 | 2017-12-20 | Manufacturing method of royal jelly material, royal jelly material, food and drink containing royal jelly, and cosmetics containing royal jelly |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP6985666B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7351529B2 (en) * | 2018-05-18 | 2023-09-27 | 株式会社山田養蜂場本社 | Stabilization of enzymatically degraded royal jelly |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04316458A (en) * | 1991-04-15 | 1992-11-06 | Kanebo Ltd | Royal jelly extract and its preparation |
| JPH06276996A (en) * | 1993-03-31 | 1994-10-04 | Ajinomoto Co Inc | Seasoning and its production |
| JPH0984556A (en) * | 1995-09-27 | 1997-03-31 | Q P Corp | Method for producing dried egg white with high gel strength |
| JP2006219434A (en) * | 2005-02-10 | 2006-08-24 | Kyoei Kagaku Kogyo Kk | Cosmetics |
| JP2006280249A (en) * | 2005-03-31 | 2006-10-19 | Sanki Shoji Kk | Royal jelly-containing food composition and method for producing the same |
| JP2008194031A (en) * | 2007-01-17 | 2008-08-28 | Yamada Bee Farm Corp | Stabilization of enzyme-treated royal jelly |
| JP2008295307A (en) * | 2007-05-29 | 2008-12-11 | Q P Corp | Fixing and manufacturing method thereof |
| JP2011152103A (en) * | 2010-01-28 | 2011-08-11 | Api Co Ltd | Royal jelly-containing composition |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5232726B2 (en) * | 2008-06-04 | 2013-07-10 | 森川健康堂株式会社 | Method for producing royal jelly having blood pressure lowering action |
| JP5592640B2 (en) * | 2009-11-30 | 2014-09-17 | アピ株式会社 | Antistress agent containing lactic acid bacteria fermented royal jelly, method for producing the same, hypothalamus-pituitary-adrenocortical activity inhibitor, and sympathetic-adrenal medullary activity inhibitor |
| JP5916288B2 (en) * | 2011-02-07 | 2016-05-11 | 森川健康堂株式会社 | Process for producing innate immunity activator with enhanced innate immunity promoting action and royal jelly-derived innate immunity activator produced by the process |
-
2017
- 2017-12-20 JP JP2017243972A patent/JP6985666B2/en active Active
-
2018
- 2018-04-03 JP JP2018071633A patent/JP7057939B2/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04316458A (en) * | 1991-04-15 | 1992-11-06 | Kanebo Ltd | Royal jelly extract and its preparation |
| JPH06276996A (en) * | 1993-03-31 | 1994-10-04 | Ajinomoto Co Inc | Seasoning and its production |
| JPH0984556A (en) * | 1995-09-27 | 1997-03-31 | Q P Corp | Method for producing dried egg white with high gel strength |
| JP2006219434A (en) * | 2005-02-10 | 2006-08-24 | Kyoei Kagaku Kogyo Kk | Cosmetics |
| JP2006280249A (en) * | 2005-03-31 | 2006-10-19 | Sanki Shoji Kk | Royal jelly-containing food composition and method for producing the same |
| JP2008194031A (en) * | 2007-01-17 | 2008-08-28 | Yamada Bee Farm Corp | Stabilization of enzyme-treated royal jelly |
| JP2008295307A (en) * | 2007-05-29 | 2008-12-11 | Q P Corp | Fixing and manufacturing method thereof |
| JP2011152103A (en) * | 2010-01-28 | 2011-08-11 | Api Co Ltd | Royal jelly-containing composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7057939B2 (en) | 2022-04-21 |
| JP2018102292A (en) | 2018-07-05 |
| JP6985666B2 (en) | 2021-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5001847B2 (en) | Cellooligosaccharide-containing composition | |
| JP5528718B2 (en) | Glucan composition elevation inhibitor and insulin secretagogue using β-glucan composition | |
| JP2023093606A (en) | oral composition | |
| JP4286254B2 (en) | Glycemic index reducing composition and food | |
| JP5479754B2 (en) | Powdered composition and tablet, and method for preventing browning of γ-aminobutyric acid and browning inhibitor | |
| JP7057939B2 (en) | Manufacturing method of royal jelly material, royal jelly material, food and drink containing royal jelly, and cosmetics containing royal jelly | |
| JP5502449B2 (en) | Intestinal flora balance improving agent and method for producing the same | |
| JP7040898B2 (en) | Oral composition for promoting type III collagen production containing a hydrolyzed eggshell membrane component as an active ingredient | |
| JP2978332B2 (en) | Intestinal metabolism improving food and intestinal metabolism improving agent | |
| JP2011152103A (en) | Royal jelly-containing composition | |
| JP6420896B2 (en) | Powder enzyme preparation, production method thereof, and use thereof | |
| WO2022075222A1 (en) | Growth promoter for intestinal bacteria, blood glucose lowering agent, serum cholesterol lowering agent, and food or beverage composition containing same | |
| CN113855587A (en) | Composition for inhibiting Maillard reaction and application thereof | |
| TWI786105B (en) | Agent for lowering the amount of phenolic compounds in a living body | |
| CN110075128A (en) | A kind of pharmaceutical compositions for being used to enhance immune function comprising enzyme treated bee milk powder as effective component | |
| JP6061622B2 (en) | Liquid composition containing pearl barley extract | |
| JP2023166032A (en) | solid preparation | |
| JP7689491B2 (en) | Method for protecting useful microorganisms | |
| JP2001103918A (en) | Method for improving gustatoriness and gustatoriness- improved persimmon juice preparation | |
| JP2006075085A (en) | Fermented product obtained from parsley | |
| WO2018062354A1 (en) | Intestinal microbiota improving agent and intestinal microbiota improving composition that include eggshell membrane–containing powder | |
| JP6607409B2 (en) | Oral composition | |
| JP2018052854A (en) | Composition for improving intestinal flora containing powder containing eggshell membrane as an active ingredient | |
| KR20160128822A (en) | Composition of Enzyme Food for Strengthening Scalp Hair and Manufacturing Method Thereof | |
| JP2021187792A (en) | Hematopoietic stem cell count increasing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201106 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210825 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210907 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211026 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220308 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220328 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7057939 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |